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Abstract
Angiogenesis, the sprouting of new capillaries from existing blood vessels, is essential for the survival of
tissues and normally occurs during development and wound healing. Successful vascularization of engineered
tissues is currently a major challenge, as it is critical for the survival and incorporation of implanted tissue
replacements. While the role of soluble factors in regulating angiogenesis is well established, there is
significant interest in uncovering the contributions of cellular interactions with the extracellular matrix
(ECM). We chose to study the role of cell-ECM adhesion in regulating angiogenesis, with the hypothesis that
quantitative changes in the degree of cell-ECM adhesion can regulate endothelial cell behaviors important for
angiogenesis. We also hypothesized that we could employ our basic knowledge of angiogenesis to develop a
synthetic material system to support vascularization for potential applications in tissue engineering.
We first examined whether quantitative changes in cell-ECM adhesion regulate angiogenesis and observed
increased angiogenic sprouting in three-dimensional fibrin gels with progressively decreasing densities of
fibrin. Examining changes in global gene expression, we demonstrated a vascular endothelial growth factor
(VEGF)-induced upregulation of genes associated with vascular invasion and remodeling when cell adhesion
was limited, whereas cells on highly adhesive surfaces upregulated genes associated with proliferation. We
showed that proline-rich tyrosine kinase 2 (Pyk2) regulates both gene expression and endothelial sprouting
through its enhanced activation by VEGF in limited adhesion contexts. These results suggest that limited cell
adhesion can enhance endothelial responsiveness to VEGF and demonstrate a novel role for Pyk2 in the
adhesive regulation of angiogenesis.
Finally, we have developed poly(ethylene glycol) (PEG)-based hydrogels that support three-dimensional
angiogenic sprouting. By tuning the mechanical, adhesive, and degradable parameters of these wholly
synthetic materials, we have begun to identify conditions optimal for vascularization, as well as provided a
tool to isolate the effects of single ECM parameters. We have demonstrated control of angiogenic sprouting by
the MMP sensitivity of the hydrogels, as well as an interplay between ECM stiffness and adhesive ligand
density in regulating sprouting.
Together, these studies highlight the importance of cellular interactions with the ECM in regulating
angiogenesis and demonstrate a path by which we can apply basic understanding toward vascularization of
engineered tissues for tissue regeneration and repair.
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ABSTRACT 
REGULATION OF ANGIOGENESIS BY ADHESIVE AND MECHANICAL CUES  
FROM THE EXTRACELLULAR MATRIX 
Colette Shen 
Supervisor:  Christopher Chen 
 
 
Angiogenesis, the sprouting of new capillaries from existing blood vessels, is 
essential for the survival of tissues and normally occurs during development and wound 
healing.  Successful vascularization of engineered tissues is currently a major challenge, 
as it is critical for the survival and incorporation of implanted tissue replacements.  While 
the role of soluble factors in regulating angiogenesis is well established, there is 
significant interest in uncovering the contributions of cellular interactions with the 
extracellular matrix (ECM).  We chose to study the role of cell-ECM adhesion in 
regulating angiogenesis, with the hypothesis that quantitative changes in the degree of 
cell-ECM adhesion can regulate endothelial cell behaviors important for angiogenesis.  
We also hypothesized that we could employ our basic knowledge of angiogenesis to 
develop a synthetic material system to support vascularization for potential applications 
in tissue engineering.   
We first examined whether quantitative changes in cell-ECM adhesion regulate 
angiogenesis and observed increased angiogenic sprouting in three-dimensional fibrin 
gels with progressively decreasing densities of fibrin.  Examining changes in global gene 
expression, we demonstrated a vascular endothelial growth factor (VEGF)-induced 
upregulation of genes associated with vascular invasion and remodeling when cell 
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adhesion was limited, whereas cells on highly adhesive surfaces upregulated genes 
associated with proliferation.  We showed that proline-rich tyrosine kinase 2 (Pyk2) 
regulates both gene expression and endothelial sprouting through its enhanced activation 
by VEGF in limited adhesion contexts. These results suggest that limited cell adhesion 
can enhance endothelial responsiveness to VEGF and demonstrate a novel role for Pyk2 
in the adhesive regulation of angiogenesis. 
Finally, we have developed poly(ethylene glycol) (PEG)-based hydrogels that 
support three-dimensional angiogenic sprouting.  By tuning the mechanical, adhesive, 
and degradable parameters of these wholly synthetic materials, we have begun to identify 
conditions optimal for vascularization, as well as provided a tool to isolate the effects of 
single ECM parameters.  We have demonstrated control of angiogenic sprouting by the 
MMP sensitivity of the hydrogels, as well as an interplay between ECM stiffness and 
adhesive ligand density in regulating sprouting.   
Together, these studies highlight the importance of cellular interactions with the 
ECM in regulating angiogenesis and demonstrate a path by which we can apply basic 
understanding toward vascularization of engineered tissues for tissue regeneration and 
repair. 
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CHAPTER 1 
INTRODUCTION/BACKGROUND 
 
 
 
1.1 Rationale and Hypotheses 
 
Angiogenesis is a critical regulator of tissue function in both healthy and diseased 
states:  vascularization of normal tissues provides essential oxygen and nutrients during 
development and wound healing, while dysregulated angiogenesis associated with 
diseases such as cancer and diabetic retinopathy further contributes to disease 
progression.  Understanding how angiogenesis is regulated by the microenvironment, 
then, is crucial for maintaining the survival and health of implanted tissues for 
regenerative medicine, as well as identifying ways to curb angiogenesis as one avenue to 
treat cancers and diabetic retinopathy.  The general goal of this thesis is to elucidate 
further how cellular interactions with the ECM regulate angiogenesis and to apply this 
knowledge toward engineering materials that promote vascularization.  A major 
hypothesis is that changes in the degree of cell adhesion to the ECM regulate distinct 
endothelial cell behaviors important for angiogenesis.  We also hypothesize that by 
controlling various ECM parameters—including adhesive ligand presentation, 
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mechanical stiffness, and degradability—in a synthetic material system, we can control 
the extent of vascularization to enable efforts in tissue engineering.  The remainder of this 
chapter provides background on what is currently known about ECM regulation of 
angiogenesis, as well as existing engineered materials used to study tissue 
vascularization.  
 
1.2 Clinical Relevance 
 
Cardiovascular disease is the leading cause of death and disability in the U.S. and 
most Western countries.  This mostly is due to the narrowing and eventual blockage of 
blood vessels to the normal flow of blood, causing tissue ischemia and damage.  As such, 
therapeutic interventions to treat cardiovascular disease include strategies to revascularize 
these ischemic tissues.  Among the two most common surgical procedures for coronary 
or peripheral vascular disease are the placement of stents (to re-open narrowing vessels 
physically) or introduction of a bypass graft to circumvent diseased vessels.  While such 
approaches have proven to be widely successful in cases where vascular disease is 
restricted to large vessels, in many settings the limitation for blood flow is in the 
microvasculature.  In this setting, it is clear that the most promising approach is to 
promote the formation of additional microvessels in the ischemic tissue.  In addition to 
what is now referred to as “therapeutic angiogenesis,” our ability to promote controlled 
neovascularization is also critical to the success of tissue engineering as a strategy for 
organ replacement.  Currently, investigators have demonstrated a number of promising 
avenues to engineer cells and biomaterials to form tissue-like structures in culture.  Our 
ability to translate these in vitro tissues into transplantable replacement tissues is now 
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limited by our ability to promote the successful vascularization of the engineered 
constructs.  As most cells must reside within 200μm of the nearest capillary for proper 
gas exchange, nutrient delivery, and waste removal (Jain, 1999; Jain et al., 2005), a 
failure to vascularize an engineered implant would either result in massive failure of the 
implant or limit us to implant only tiny structures.   
Historically, the strategies for promoting angiogenesis in these clinical settings 
have focused largely on gene- and cell-based therapies for delivering angiogenic 
cytokines and progenitor cells to promote neovascularization (Renault and Losordo, 
2007).  Studies of the fundamental process of angiogenesis over the past decade have 
revealed that in addition to the appropriate cells and soluble factors, the extracellular 
matrix (ECM) environment is also a critical regulator that can either promote or prevent 
neovascularization of a tissue.   
 
1.3 Regulation of angiogenesis by the microenvironment 
 
Angiogenesis is the sprouting of new capillaries from existing vessels and 
involves the activation of quiescent endothelium to degrade the surrounding ECM, 
proliferate and migrate away from existing vessels, and assemble to form hollow, 
elongated, branching tubes (Adams and Alitalo, 2007).  Angiogenesis requires the 
cooperative signaling of both soluble growth factor and matrix-mediated adhesive and 
mechanical cues (Fig. 1.1).  Several growth factors are known to regulate various aspects 
of angiogenesis, among them vascular endothelial growth factor (VEGF), basic fibroblast 
growth factor (bFGF), placental growth factor (PlGF), and platelet-derived growth factor 
(PDGF).  Studies of angiogenesis in tumors have revealed that inhibition of VEGF, 
bFGF, PDGF, and, more recently, PlGF signaling blocks angiogenesis (Drevs et al., 
2002; Ferrara, 2004; Levin et al., 2004).  Clinically, these inhibitors potently inhibit 
angiogenesis in certain cancers and in diabetic retinopathy (Cabebe and Fisher, 2007; 
Ferrara, 2004; Goodman, 2004; Hanrahan and Heymach, 2007; Hilberg et al., 2008; 
Manegold, 2008; Simo and Hernandez, 2008).  Likewise, agents that block endothelial 
cell adhesion to ECM profoundly inhibit angiogenesis in animal studies, and these 
approaches are being assessed as potential clinical cancer treatments (Drake et al., 1995; 
Gutheil et al., 2000; Hood et al., 2002; Trikha et al., 2004).   
 
 
Figure 1.1.  Microenvironmental regulation of angiogenesis.  The various steps of 
angiogenesis (basement membrane degradation, proliferation and migration away from 
an existing vessel, and capillary morphogenesis) are regulated by soluble growth factors 
and cellular interactions with the extracellular matrix.  Adapted from (Ingber, 2002). 
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1.4 Regulation of angiogenesis by cell adhesion to extracellular matrix 
  
While the mechanisms by which soluble factors promote angiogenesis are 
relatively straightforward, how cell adhesion to the ECM modulates endothelial cell 
behavior requires a more careful examination of the literature.  Cell adhesion involves 
binding of integrins to ECM ligands, as well as cell spreading against the substrate and 
subsequent generation of cytoskeletal tension.  Each of these different aspects of 
adhesion (integrin binding, changes in cell shape, and alterations in cytoskeletal 
mechanics) appears to impact endothelial cell function.    
The importance of integrin-mediated adhesion in angiogenesis has been well 
established:  antagonists of αvβ3, αvβ5, α5β1, α1β1, and α2β1 have been shown to inhibit 
endothelial cell adhesion and migration in vitro and angiogenesis in vivo using the chick 
chorioallantoic membrane (CAM) model (Fig. 1.2A) or vascularization of human skin 
transplanted onto SCID mice (Brooks et al., 1994a; Friedlander et al., 1995; Kim et al., 
2000; Senger et al., 1997).  Interestingly, these integrins are not highly expressed on 
quiescent endothelium but are upregulated in tumors, wounds, and sites of inflammation 
and in response to angiogenic growth factors (Avraamides et al., 2008).  These integrins 
appear to regulate diverse angiogenic pathways, as blocking engagement of αvβ3 and 
α5β1 integrins inhibits basic fibroblast growth factor (bFGF)-induced angiogenesis, while 
blocking αvβ5, α1β1, and α2β1 engagement inhibits VEGF-induced angiogenesis.  
Integrin knockout studies, on the other hand, suggest certain integrins—αv, β3, β5, α1, 
and α2—are not always necessary for vascular development (Bader et al., 1998; 
Hodivala-Dilke et al., 1999; Huang et al., 2000; Pozzi et al., 2000; Zhang et al., 2008).  
 Figure 1.2.  Cell adhesion to the ECM regulates angiogenesis.  (A) Tumor 
angiogenesis on the chick chorioallantoic membrane (CAM) is inhibited by cyclic RGD 
peptide, which antagonizes integrin αvβ3 binding to the ECM. From (Brooks et al., 
1994b).  (B) The degree of cell spreading, controlled by varying sizes of micropatterned 
islands of fibronectin, regulates endothelial cell proliferation versus apoptosis, with 
greater proliferation in more highly spread cells.  From (Chen et al., 1997).  (C) Low 
concentrations of the αvβ3/αvβ5 inhibitors S 36578 and cilengitide promote VEGF-
mediated angiogenesis from mouse aortic rings, compromising anti-angiogenic effects.  
From (Reynolds et al., 2009). 
6 
 
7 
 
These discrepancies can be explained in part by compensatory upregulation of other 
angiogenesis signaling pathways, such as VEGF receptor 2 signaling in β3-null mice 
(Reynolds et al., 2004) and VEGF receptor 1 signaling in α2-null mice (Zhang et al., 
2008), though these studies still leave many questions unanswered.  
The molecular intermediaries by which integrin engagement impacts endothelial 
cell behavior are largely found in focal adhesions.  Binding and clustering of integrins to 
specific ECM ligands leads to the recruitment of numerous scaffolding and signaling 
proteins to the site of integrin ligation, forming these dynamic structures known as focal 
adhesions (Burridge et al., 1988; Miyamoto et al., 1995; Plopper et al., 1995).  Signaling 
proteins (e.g., FAK, Src, ERK, RhoA) that are regulated by integrin activation also 
function in growth factor signaling, suggesting that focal adhesions act to coordinate 
integrin and growth factor signaling (Schwartz, 1997; Stupack and Cheresh, 2004).  
Indeed, growth factor receptors are concentrated within sites of focal adhesion formation 
(Plopper et al., 1995), and different integrins within focal adhesions interact with specific 
growth factor receptors (Mettouchi et al., 2001; Schneller et al., 1997).  For example, 
VEGF and bFGF signal synergistically with integrins αvβ5 and αvβ3, respectively, to 
activate the Ras-Erk pathway to modulate angiogenesis (Hood et al., 2003).  Focal 
adhesion kinase (FAK), a key signaling protein localized to focal adhesions, is known to 
transduce both soluble growth factor and integrin adhesion signals to regulate cell 
proliferation, migration, and survival (Parsons, 2003; Pirone et al., 2006; Schober et al., 
2007; Vadali et al., 2007).  Importantly, FAK is essential for vascular development in 
vivo as demonstrated by the embryonic lethality of endothelial-specific FAK knockout in 
mice (Braren et al., 2006; Shen et al., 2005).  Further downstream, sustained ERK 
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activity in response to growth factor and integrin-mediated adhesive cues is required for 
angiogenesis in vivo (Eliceiri et al., 1998).  Such studies provide a molecular context for 
how cell adhesion can modulate growth factor-mediated responses and emphasize the 
importance of integrin-mediated adhesion in transducing signals from the ECM.   
While these studies clearly demonstrate the importance of integrin-mediated 
adhesion in regulating angiogenesis, several studies also suggest that the degree of cell 
adhesion and spreading can strongly impact endothelial cell behavior.  Varying cell 
spreading by changing the density of the ECM protein, fibronectin, immobilized on 
culture surfaces results in increased proliferation at high densities and quiescence at low 
densities (Ingber, 1990; Ingber and Folkman, 1989).  The use of micropatterned 
substrates with defined adhesive and surrounding non-adhesive regions extended these 
findings further.  Such substrates dictate the area of cell-ECM contact and allow for more 
precise control of cell adhesion and shape (Singhvi et al., 1994).  Controlling cell 
spreading by culturing cells on different sizes of adhesive islands showed greater 
proliferation in endothelial cells cultured on large adhesive islands and an increase in 
apoptosis on small adhesive islands (Fig. 1.2B) (Chen et al., 1997).  Interestingly, 
between these two extremes of high and low spreading, studies have shown enhanced 
cell-cell interaction and tubulogenesis at intermediate levels of adhesion.  Intermediate 
cell-ECM adhesion, achieved either by introducing antibodies that block integrin binding 
or by coating substrates with intermediate amounts of ECM protein, resulted in increased 
tubulogenesis, decreased spreading, and decreased proliferation in vitro (Gamble et al., 
1993; Ingber and Folkman, 1989).  Similarly, confining endothelial cells on patterned 
adhesive lines of intermediate width promoted morphogenesis of cells into tubules with 
lumens (Dike et al., 1999).  A recent study also demonstrated an unexpected increase in 
tumor angiogenesis in vivo in response to low concentrations of RGD-mimetic integrin 
inhibitors, under development as anti-angiogenic cancer therapeutics (Fig. 1.2C) 
(Reynolds et al., 2009).  A biphasic response was observed, such that no inhibitor had 
minimal effect on angiogenesis, high concentrations of inhibitor decreased angiogenesis, 
but intermediate concentrations actually increased angiogenesis above baseline levels.  
These studies all point to the possibility of enhanced capillary differentiation and 
angiogenesis at intermediate levels of adhesion (Fig. 1.3). 
 
 
Figure 1.3.  Endothelial cell behavior is regulated by adhesion.  Changes in the degree 
of cell-ECM adhesion result in a switch between apoptosis, tubulogenesis, and 
proliferation. 
 
 
Given the dynamic nature of cell invasion and sprouting during angiogenesis, the 
adhesive interaction between endothelial cells and the ECM is constantly changing.  
Matrix degradation leads to release of ECM fragments and exposure of cryptic binding 
sites, and new matrix deposition provides additional ECM ligands for integrin ligation.  
Specifically, denatured collagen is found around angiogenic, but not quiescent, vessels 
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(Brooks et al., 1996), and collagen type IV cleavage reveals cryptic binding sites that 
interact preferentially with αvβ3 integrins upregulated in angiogenic vessels over α1β1 
integrins (Xu et al., 2001).  The importance of adhesive interactions with these cryptic 
sites is evidenced by the inhibition of angiogenesis in vivo with antibodies directed 
against these sites.  Proteolytic activity also results in release of fragments of ECM 
proteins and proteases, all of which can ligate integrins and have been shown to block 
angiogenesis by altering integrin interactions with the ECM.  These include endostatin, a 
fragment of collagen XVIII (O'Reilly et al., 1997); tumstatin, a fragment of collagen IV 
(Maeshima et al., 2000); angiostatin, a fragment of plasminogen (O'Reilly et al., 1994); 
and PEX, a fragment of matrix metalloproteinase 2 (MMP-2) (Brooks et al., 1998).  
Finally, new matrix deposition—either from the plasma as a result of increased 
endothelial permeability or directly produced by endothelial and supporting 
mesenchymal cells—provides additional ligands for adhesion.  Fibronectin, vitronectin, 
and fibrinogen are among the provisional matrix proteins deposited from the plasma, and 
tenascin and thrombospondins are provisional ECM proteins produced by endothelial 
cells (Davis and Senger, 2005; Stupack and Cheresh, 2004).  Returning full circle, 
endothelial-pericyte interactions appear to enhance production of basement membrane 
proteins such as laminins, collagen IV, and nidogens to stabilize newly formed vessels 
(Stratman et al., 2009a).  These examples underscore not only the importance of the 
adhesive interactions between endothelial cells and the ECM in modulating angiogenesis, 
but also the complex dynamic nature of the entire process. 
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Figure 1.4. Cell contractility and ECM mechanical properties regulate angiogenesis.  
(A) Increased cell spreading increases cell contractility, as measured by culture on arrays 
of flexible micro-posts.  From (Tan et al., 2003).  (B) RhoA manipulations regulate 
VEGF-driven angiogenesis in mouse skin.  From (Hoang et al., 2004).  (C) Fibrin density 
regulates endothelial cell sprouting from microcarrier beads, with higher densities 
inhibiting sprouting.  From (Ghajar et al., 2008a).  (D) Intermediate stiffness of Matrigel 
promotes angiogenesis in vivo as measured by cellular infiltration and VEGFR2 
expression.  From (Mammoto et al., 2009). 
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1.5 Mechanical regulation of angiogenesis  
 
As cells attach and spread against an ECM substrate, RhoA and its effector 
ROCK are activated, leading to actin-myosin-generated contractility and further 
maturation of focal adhesions (Amano et al., 1996; Chrzanowska-Wodnicka and 
Burridge, 1996; Ishizaki et al., 1996; Kimura et al., 1996).  Studies from our group and 
others have demonstrated that progressively increasing cell spreading activates RhoA-
ROCK- and myosin-mediated cytoskeletal tension, along with enhanced assembly of 
robust stress fibers and focal adhesions (Bhadriraju et al., 2007; Chen et al., 2003; 
McBeath et al., 2004; Pirone et al., 2006; Polte et al., 2004; Ren et al., 2004).  Using a 
microfabricated device containing arrays of microneedles that directly reports traction 
forces (Tan et al., 2003), we demonstrated that the degree of cell spreading regulates the 
magnitude of cytoskeletal tension generated by cells cultured on the posts (Fig. 1.4A).  
Together, these studies demonstrate a tight link between cellular mechanics and cell 
adhesion. 
Importantly, these changes in cell contractility appear to be critical in modulating 
endothelial cell function.  For example, RhoA-ROCK-mediated contractility is key in 
regulating proliferation (Pirone et al., 2006), and Ingber and colleagues have shown that 
cell spreading-mediated changes in RhoA signaling regulate the G1/S transition in cell 
cycle progression by increasing expression of the transcriptional regulator Skp2 (Huang 
et al., 1998; Mammoto et al., 2004).  RhoA-ROCK-mediated contractility has also been 
shown to be important for endothelial cell migration and capillary morphogenesis in vitro 
and angiogenesis in vivo (Fig. 1.4B) (Bryan and D'Amore, 2007; Hoang et al., 2004; Liu 
and Senger, 2004; Uchida et al., 2000; van Nieuw Amerongen et al., 2003), and directly 
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inhibiting myosin signaling or disrupting the actin cytoskeleton decreases capillary 
sprouting and endothelial cell proliferation (Huang et al., 1998; Kniazeva and Putnam, 
2009).   
Given that ECM stiffness has been reported to increase cellular contractility, 
might the mechanical properties of the ECM also regulate angiogenesis via alteration of 
cell-generated tension against the ECM?  Increases in matrix stiffness have been shown 
in other cell types to activate FAK, RhoA-ROCK, and myosin activity (Engler et al., 
2006; Paszek et al., 2005; Wozniak et al., 2003).  Furthermore, the combination of 
increased contractility and increased rigidity of the substrate against which cells pull 
leads to higher stresses generated between the cell and substrate.  Studies suggest that it is 
the tension generated when cells pull against a rigid substrate, rather than contractile 
activity within cells themselves, that drives cell function.  In the absence of adhesion to a 
rigid substrate, activation of RhoA cannot generate cytoskeletal tension and fails to 
support focal adhesion formation or proliferative signaling (Assoian and Schwartz, 2001; 
Bhadriraju et al., 2007; Ren et al., 1999; Ren et al., 2004; Renshaw et al., 1996).   
Early studies demonstrated changes in endothelial cell behavior when grown on 
malleable substrates versus on traditional rigid tissue culture surfaces—for example, the 
arrangement of endothelial cells into capillary tubes on soft gels and into monolayers on 
rigid surfaces (Montesano et al., 1983; Schor et al., 1983)—and have suggested the 
possibility that mechanical cues from the ECM indeed play an important role in 
regulating endothelial cell behavior.  However, only recently have the tools to study the 
role of matrix elasticity in angiogenesis well become available.  Primarily in other 
biological contexts, matrix stiffness has been shown to regulate numerous cellular 
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behaviors, including adhesion, contractility, spreading, motility, proliferation, and 
differentiation (Discher et al., 2005; Engler et al., 2006; Paszek et al., 2005; Pelham and 
Wang, 1997; Peyton et al., 2006; Wang et al., 2000; Wozniak et al., 2003; Yeung et al., 
2005).  In studies with endothelial cells, it has been shown using natural ECMs such as 
fibrin and Matrigel that lower density and thus more compliant matrices tend to support 
capillary morphogenesis, while denser and thus more rigid matrices promote endothelial 
proliferation and migration (Fig. 1.4C) (Ghajar et al., 2006; Nehls and Herrmann, 1996; 
Sieminski et al., 2004; Vailhe et al., 1997).  Matrix compliance is but one of many 
properties varied in these ECMs, however, and endothelial cell responses have been 
attributed to limitations in diffusion and changes in MMP production in addition to 
compliance (Ghajar et al., 2006; Ghajar et al., 2008a).  To address this shortcoming, 
others have varied the stiffness of collagen gels by using glycation-induced crosslinking, 
while holding collagen density constant.  Consistent with studies varying ECM density, 
increased ECM stiffness suppresses tubulogenesis while increasing proliferation (Kuzuya 
et al., 1998).  Because crosslinking of the matrix itself can locally alter ligand density, 
hydration state, flexibility, or conformation (thereby affecting cell adhesion through 
changes in integrin binding rather than by mechanical effects), investigators have 
developed non-adhesive hydrogels, such as polyacrylamide or poly(ethylene glycol) 
(PEG), where crosslinking occurs on the non-adhesive backbone, and the ECM ligand is 
covalently attached in a separate chemical step to decouple ECM ligand density from 
stiffness manipulations (Mann et al., 2001a; Pelham and Wang, 1997).  Gelatin-coupled 
polyacrylamide gels of different stiffness exhibit enhanced tubulogenesis on more 
compliant matrices (Deroanne et al., 2001).  In addition, a recent study demonstrated 
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enhanced angiogenesis at an intermediate stiffness of Matrigel in vivo (where stiffness 
was controlled by transglutaminase-mediated protein crosslinking) (Fig. 1.4D) and 
showed that related endothelial cell responses are similarly biphasic on 2-dimensional 
polyacrylamide gels of varying stiffness (Mammoto et al., 2009). 
Although these studies are beginning to uncover a role for matrix mechanics in 
angiogenesis, it should be cautioned that mechanical properties of tissues could be 
dynamically changing over time due to degradation by cellular proteases and deposition 
of new matrix proteins, so studies of matrix stiffness currently can only accurately report 
effects of initial mechanical properties.  In angiogenesis, membrane type 1 MMP (MT1-
MMP, or MMP14) has been shown to be particularly important and is highly expressed at 
the tips of angiogenic sprouts (Chun et al., 2004; Collen et al., 2003; Ghajar et al., 2006; 
Hiraoka et al., 1998; Lafleur et al., 2002; Stratman et al., 2009b; Yana et al., 2007).  It is 
possible, then, that a certain local mechanical compliance—different from initial 
conditions—must be reached before sprout invasion into a matrix can occur.  However, 
the rate of sprouting into matrices of different initial stiffness should vary, as may the 
character of sprouting given the differences in angiogenesis in stiffer tumor tissues versus 
softer healthy tissues.  Mechanical gradients along sprouts resulting from differential 
matrix degradation and deposition also point to the importance of studying relative 
differences in mechanical properties on angiogenesis, even if initial conditions are not 
maintained.  Finally, studies have suggested that increased mechanical stiffness can 
increase matrix deposition (Khatiwala et al., 2006; Li et al., 2007), resulting in a positive 
feedback loop that could significantly impact the dynamic properties of the ECM 
surrounding angiogenic vessels. 
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It can be appreciated from these studies that not only the extent but also the 
quality or character of angiogenesis could potentially be controlled simply by changing 
the adhesive or mechanical properties of the ECM.  Shifts in cellular responses to these 
manipulations from proliferation to capillary morphogenesis and apoptosis, all in the 
presence of similar soluble factor conditions, could alter the overall architecture of 
vascular networks as they form.  Such a perspective could potentially help explain why 
certain cells in an angiogenic sprout proliferate while others undergo capillary 
morphogenesis, as well as why pathological angiogenesis varies so much in character 
from normal angiogenesis.  The similar trends in angiogenic responses to changes in the 
amount of integrin-mediated adhesion, cell spreading, and matrix compliance suggest that 
perhaps similar downstream signaling pathways are responding to control cellular 
responses.  Importantly, we can also use these findings to inform our efforts to 
vascularize engineered tissues for tissue regeneration using rationally designed materials. 
 
1.6 Engineered materials to promote vascularization 
 
Given current understanding of how adhesive and mechanical properties of the 
ECM regulate angiogenesis, a major goal is to employ this knowledge toward 
engineering materials to promote optimal vascularization for tissue engineering and 
therapeutic angiogenesis.  While most current strategies focus on soluble factor delivery 
to induce neovascularization of ischemic tissue or material implants, it is clear that proper 
signals from the ECM are also required for optimal tissue vascularization.  Soluble 
angiogenic factors, such as VEGF and bFGF, delivered by either controlled-release 
scaffolds or transfected cells, cannot attract native microvessels into the implanted 
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construct without the appropriate adhesive cues from the ECM (Hall, 2007; Leslie-
Barbick et al., 2009; Lutolf and Hubbell, 2005; Zisch et al., 2003).  Conversely, ECMs 
designed specifically to promote vascularization of implanted tissues require soluble 
growth factors for efficient angiogenesis (Cai et al., 2005; Perets et al., 2003; Smith et al., 
2004; Tanihara et al., 2001; Yoon et al., 2006), highlighting the importance of both 
soluble and matrix cues in engineered systems for angiogenesis.    
In engineering materials for angiogenesis, we can use principles guided by our 
studies of angiogenesis in natural ECMs.  In vivo, sprouting angiogenic vessels first 
degrade and migrate through laminin- and collagen IV-rich basement membrane that 
surrounds quiescent vessels, then extend into an interstitial matrix containing collagen I 
and provisionally deposited fibrin and fibronectin matrices (Carmeliet, 2003).  Many 
studies of tissue implant vascularization, as well as in vitro systems to investigate the 
mechanisms and processes involved in angiogenesis, use these natural ECMs.  They 
provide the adhesive, mechanical, and degradable properties known to promote robust 
vascularization in tissues in vivo, as well as the ability to tether and retain soluble growth 
factors via heparin binding sites (Ramirez and Rifkin, 2003), another important signal for 
vessel ingrowth.  In a key study in efforts to engineer functional, stable vessels, Jain and 
colleagues implanted type I collagen scaffolds containing endothelial and mesenchymal 
precursor cells in mice and reported the assembly of vascular networks that anastomosed 
with the host vasculature and remained stable for several months (Fig. 1.5A) (Koike et 
al., 2004).  Similar results were reported with the implantation of endothelial progenitor 
cells and smooth muscle cells in laminin-rich Matrigel (Melero-Martin et al., 2007) and 
pre-formed endothelial cell spheroids in a fibrin-Matrigel matrix (Alajati et al., 2008).   
  
Figure 1.5.  Engineering materials to promote tissue vascularization.  (A) Endothelial 
cells and pericytes co-seeded in collagen gel implants begin to form vascular networks at 
4 days (left) and are stable and fully perfused at 4 months (right).  From (Koike et al., 
2004).  (B) One synthetic scheme used to create biomimetic PEG materials.  Mono-
cysteine adhesive peptides and bis-cysteine MMP-sensitive peptides are coupled to 
multiarm PEGs via Michael-type addition reaction to allow cell migration through the 
matrix.  From (Lutolf et al., 2003b). 
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Several others have employed in vitro assays of capillary sprouting or morphogenesis in 
fibrin and type I collagen matrices to uncover the contribution of supporting 
mesenchymal cells and MMPs in these processes, as well as the signaling mechanisms 
regulating vessel invasion and lumen formation (Bayless and Davis, 2002; Bayless and 
Davis, 2003; Ghajar et al., 2006; Griffith et al., 2005; Koh et al., 2008; Nakatsu et al., 
2003; Sainson et al., 2005; Saunders et al., 2006; Stratman et al., 2009b).  As noted 
above, the adhesive and mechanical properties of these natural ECMs can be altered to 
some extent by varying matrix density, resulting in variations in angiogenic behavior; 
however, changes in density are accompanied by changes in adhesive ligand 
concentration, mechanical stiffness, degradability, and porosity, so the exact contribution 
of each parameter to angiogenic responses cannot easily be determined.   
Because of such limitations, despite the availability and known vascularization 
potential of natural ECMs, investigators continue to create increasingly synthetic systems 
in attempts to control more precisely material parameters such as compliance, adhesive 
ligand density and type, and porosity (Lutolf and Hubbell, 2005).  Synthetic materials 
also allow for covalent incorporation of known pro-angiogenic factors such as soluble 
growth factors and cell-cell guidance molecules, as well as pre-patterning of regions 
within a material to control vascularization spatially.  Some natural ECMs have been 
“engineered” to incorporate additional functionalities to enhance vascularization.  For 
instance, increased growth factor retention in fibrin and collagen matrices has been 
achieved through covalent coupling of VEGF itself (Ishikawa et al., 2006; Koch et al., 
2006; Zisch et al., 2001), heparin-binding peptides or heparin itself that promote binding 
of heparin-bound growth factors such as VEGF and bFGF (Pieper et al., 2002; Sakiyama-
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Elbert and Hubbell, 2000; Steffens et al., 2004), and collagen-mimetic peptides that 
attract growth factors to collagen gels via charge-charge interactions (Wang et al., 2008).  
Natural ECMs can also be chemically crosslinked to alter compliance independent of 
adhesive ligand density (Kuzuya et al., 1998; Standeven et al., 2007). 
Because many of these natural ECMs are derived from animal tissues and so 
present the potential risk of immunogenicity and infectious pathogens (Brown and 
Phillips, 2007; Lutolf and Hubbell, 2005), fully synthetic material systems are ultimately 
preferred for purposes of generating vascularized tissue constructs for implantation.  Two 
primary material backbones, non-toxic and approved for in vivo clinical applications, 
have been used for this purpose:  porous scaffolds formed from poly(lactic-co-glycolic 
acid) (PLGA) and PEG hydrogels functionalized with oligopeptides rendering them cell 
adhesive and degradable.  Both materials satisfy the requirements of complete 
degradation and resorption in vivo after serving as temporary mechanical supports for 
cell ingrowth.  PLGA scaffolds have long been used in medical implants such as sutures 
and prosthetic devices due to their biocompatibility and biodegradability (Athanasiou et 
al., 1996; Gunatillake and Adhikari, 2003).  Their mechanical and degradation properties 
can be altered by varying the ratio of lactic and glycolic acids.  PLGA itself is not cell 
adhesive, but when implanted it nonspecifically adsorbs proteins from fluids in the body, 
rendering implanted PLGA scaffolds cell adhesive (Miller et al., 2005; Tjia et al., 1999).  
Mooney and colleagues have demonstrated vascular ingrowth in PLGA scaffolds 
containing VEGF alone (Peters et al., 2002; Sheridan et al., 2000) and VEGF with PDGF 
(Richardson et al., 2001), with the addition of PDGF promoting the formation of mature, 
stable vessels supported by smooth muscle cells.  Langer and colleagues prevascularized 
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skeletal muscle constructs before implantation by co-seeding endothelial cells, myoblasts, 
and embryonic fibroblasts on scaffolds composed of PLGA and poly(L-lactic acid) 
(PLLA) (Levenberg et al., 2005).  They demonstrated that pre-formed vascular networks 
indeed improved the viability and vascularization of the skeletal muscle constructs after 
implantation. 
While PLGA scaffolds have proven capable of supporting vascularization in 
implanted constructs, PEG hydrogels possess significant advantages over other material 
systems as biomimetic, tunable scaffolds for engineered tissue vascularization.  Since 
natural ECMs themselves are hydrogels (Lutolf and Hubbell, 2005), the basic structure of 
PEG hydrogels is ideal for serving as a native tissue replacement.  Crosslinked polymers, 
like natural ECM protein fibrils, resist tensile stresses, while interstitial fluid resists 
compressive stresses.  Given the importance of matrix rigidity in angiogenesis, the 
mechanical tunability of PEG, by varying either its crosslinking density or chain length 
between crosslinks, is significant.  The rigidity of PEG can be varied widely, with 
reported Young’s modulus values between 300Pa-100kPa (Elbert and Hubbell, 2001; 
Lutolf and Hubbell, 2003; Raeber et al., 2005), spanning a significant range of biological 
tissues.  While PEG itself is not adhesive to proteins or cells (Gombotz et al., 1991), 
oligopeptides representing key integrin binding regions within native ECM adhesion 
proteins such as fibronectin or laminin can be covalently crosslinked to the PEG network 
(Hern and Hubbell, 1998), such that cells adhere to the PEG matrix only through those 
specific adhesive peptides, while the remaining polymer network is relatively inert.  The 
most common adhesive ligand incorporated is the ubiquitous RGD ligand (Hersel et al., 
2003), found in fibronectin, vitronectin, fibrinogen, and several other ECM adhesion 
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proteins (Ruoslahti and Pierschbacher, 1987), but other adhesive sequences such as 
IKVAV (from laminin) or REDV (from the fibronectin IIICS region) have also been 
incorporated so that the adhesive ligand can be tailored to the cell type of interest (Shin et 
al., 2003).  This synthetic scheme allows for variations of adhesive ligand density 
independent of other parameters such as stiffness and porosity, permitting investigation 
of the contributions of these material parameters to cell behavior independently.  For 
instance, independent variation of adhesive ligand density has demonstrated a biphasic 
effect of ligand density on cell migration in 3-dimensional matrices (Burgess et al., 2000; 
Gobin and West, 2002; Lutolf et al., 2003a; Schense and Hubbell, 2000) and may provide 
one explanation for the enhanced angiogenesis observed at intermediate degrees of 
adhesion (Ingber and Folkman, 1989; Reynolds et al., 2009). 
The ability to incorporate oligopeptides into a PEG backbone endows it with not 
only a cell adhesive property but also several other biological functionalities 
characteristic of natural ECMs.  Proteolytically degradable sequences allow cells to 
degrade and migrate through the material via cell-secreted proteases, as the nanometer-
scale pores in PEG hydrogels do not normally permit invasion and migration (Lutolf et 
al., 2003a; Lutolf et al., 2003b; Mann et al., 2001a).  These sequences can be tailored to 
be sensitive to various proteases, including MMPs and plasmin, and thus specific to the 
biological process being studied.  Similar to the “engineered” natural ECMs described 
earlier, growth factors can be incorporated into PEG hydrogels either directly or through 
binding to heparin (Benoit et al., 2007; Gobin and West, 2003; Mann et al., 2001b; Zisch 
et al., 2003).  The chemistry to polymerize and incorporate biological functionalities into 
PEG materials is now sufficiently well established and compatible with living cells and 
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tissues such that the material can even be polymerized in situ after encapsulation of cells.  
West and colleagues have utilized a scheme in which acrylated PEG derivatives are 
photopolymerized with proteolytically degradable and cell adhesive oligopeptides such 
that degradable sequences are incorporated in the PEG backbone, and adhesive sequences 
are attached as pendant chains (Gobin and West, 2002; Mann et al., 2001a; West and 
Hubbell, 1999).  Hubbell and colleagues employ Michael-type crosslinking reactions 
between end-functionalized PEG macromers and thiol-bearing compounds (such as the 
amino acid cysteine) to form similar degradable and adhesive matrices (Fig. 1.5B) (Elbert 
and Hubbell, 2001; Lutolf et al., 2003a; Lutolf et al., 2003b).  Recently, Anseth and 
colleagues have developed chemistries involving thiol-ene photopolymerization (Aimetti 
et al., 2009) and sequential click reactions to pattern 3D PEG hydrogels (DeForest et al., 
2009).  The end result is a biocompatible, biomimetic material that can be customed 
tailored for the biological process or tissue type being studied via modular incorporation 
of bioactive oligopeptides. 
In the context of angiogenesis, the potential for PEG hydrogels to serve as 
scaffolds for vascularization has only begun to be realized.  Hubbell and colleagues 
demonstrated enhanced angiogenesis in response to VEGF covalently bound to and then 
released from PEG scaffolds by cell-mediated proteolytic degradation (Zisch et al., 
2003).  Vascularization on the chick CAM was improved with covalently bound VEGF 
over soluble VEGF, and scaffolds implanted subcutaneously in rats were replaced by 
vascularized tissue.  West and colleagues have added several functionalities to PEG to 
improve endothelial cell function:  covalent immobilization of VEGF enhanced 
endothelial cell tubulogenesis on the surface of PEG hydrogels and migration and cell-
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cell interaction of cells encapsulated within degradable hydrogels (Leslie-Barbick et al., 
2009).  Endothelial cell adhesion and tubule formation were promoted by covalent 
incorporation of ephrin A1, a cell-cell adhesion molecule important in regulating vascular 
guidance and assembly (Moon et al., 2007).  By patterning lines of RGDS on the surface 
of PEG hydrogels, they demonstrated formation of endothelial cords only on lines of 
intermediate width, and only at intermediate RGDS concentrations (Moon et al., 2009), 
consistent with previous results demonstrating enhanced tubulogenesis at intermediate 
densities of fibronectin and on fibronectin lines of intermediate width (Dike et al., 1999; 
Ingber and Folkman, 1989).  Further techniques developed to pattern PEG hydrogels in 
2D and 3D (Hahn et al., 2006a; Hahn et al., 2006b) can potentially be used to control 
spatially the adhesive, mechanical, and degradable properties of the matrix to generate 
complex vascularized tissues.  Taking further advantage of the mechanical, adhesive, and 
degradable tunability of PEG will provide further insight into ECM regulation of 
angiogenesis and aid in the rational design of materials for tissue repair.   
 
1.7 Multicellular interactions in angiogenesis 
 
In vivo, vascular cells exist in multicellular tubular structures and rarely as single 
cells.  While studying ECM control of single endothelial cell behavior without the 
confounding contribution of cell-cell interaction is necessary, it is also crucial to develop 
a more focused understanding of the role of cell-cell adhesion itself in endothelial cell 
behavior, as well as how cell-cell interactions might affect ECM regulation of 
multicellular vascular structures.  For instance, culture of single endothelial cells on 
adhesive islands of defined area results in a switch between proliferation with high cell 
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spreading and apoptosis with low cell spreading (Chen et al., 1997).  However, it is only 
when endothelial cells are cultured on lines of fibronectin of intermediate width, 
permitting multicellular interactions, that cells differentiate into capillary tube-like 
structures (Dike et al., 1999).  While cell-cell contact is traditionally thought to inhibit 
endothelial cell proliferation (Caveda et al., 1996), our lab has observed proliferation 
within confluent sheets of endothelial cells at regions of higher stress as dictated by the 
surrounding ECM environment (Fig. 1.6A), suggesting that cytoskeletal tension 
propagated through cell-cell contacts can be an important driver of proliferation in 
physiological contexts (Nelson et al., 2005).  These observations provide one potential 
explanation for increased proliferation of stalk cells in angiogenic sprouts (Gerhardt et 
al., 2003), with migrating tip cells pulling and propagating stress toward stalk cells at the 
base of the sprouts.  In addition to propagating tension, our lab has demonstrated that 
cell-cell contact itself can activate cytoskeletal tension signaling and subsequent 
proliferation.  VE-cadherin-mediated contact normally reduced the degree of cell 
spreading and proliferation, but when cell spreading was kept constant via a 
micropatterning technique, the presence of cell-cell contact actually promoted cell 
proliferation via increased actomyosin-generated tension (Fig. 1.6B) (Nelson and Chen, 
2002; Nelson and Chen, 2003).  The decrease in cell-ECM adhesion by VE-cadherin-
mediated cell-cell adhesion could occur through several mechanisms:  cell-cell contact-
induced changes in the tension and structure of the actin cytoskeleton (Adams et al., 
1998), cadherin-induced decrease in the expression of integrins (Zhu and Watt, 1996), 
and recruitment of vinculin to cell-cell contacts away from focal adhesions (Levenberg et 
al., 1998).  Conversely, integrin-mediated adhesion has been shown to disrupt  
 Figure 1.6.  Multicellular interactions regulate angiogenesis.  (A) Confluent 
monolayers of endothelial cells proliferate at regions of higher stress:  at monolayer 
edges (top) or in valleys of undulating monolayers without edges (bottom).  From 
(Nelson et al., 2005).  (B) Cell-cell contact increases proliferation when cell spreading is 
controlled.  From (Nelson and Chen, 2003). 
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VE-cadherin-containing cell-cell junctions (Wang et al., 2006), potentially contributing to 
the initiation of angiogenic sprouting and subsequent vascular morphogenesis.  These 
results highlight the complex interplay between cell-cell and cell-ECM adhesion and the 
importance of understanding how they affect each other in the multicellular processes of 
angiogenesis.  In addition to the interaction between cell-cell and cell-ECM adhesion, 
Dejana and colleagues have importantly shown that endothelial cell-cell adhesion can 
regulate soluble VEGF signaling:  engagement of VE-cadherin at cell-cell junctions can 
sequester VEGF receptor 2 at the cell surface, preventing its internalization and 
subsequent signaling from the receptor (Grazia Lampugnani et al., 2003; Lampugnani et 
al., 2006).  This reduction in VEGF signaling in confluent monolayers provides one 
explanation for contact-dependent inhibition of proliferation and quiescence in confluent 
endothelial cells.   
In addition to the importance of homotypic endothelial cell interactions in 
angiogenesis, several recent studies have explored the role of mesenchymal support cells 
in inducing formation of and stabilizing vascular networks (reviewed in greater depth in 
(Gerhardt and Betsholtz, 2003; Hughes, 2008)).  Early work by D’Amore and colleagues 
demonstrated recruitment of 10T1/2 pericytes toward developing vessels and their 
differentiation to a smooth muscle fate by signals from endothelial cells (Hirschi et al., 
1998), as well as mutual inhibition of proliferation in pericytes and endothelial cells in 
contacting co-cultures (Hirschi et al., 1999; Orlidge and D'Amore, 1987).  These 
responses resulted from both soluble PDGF and TGF-β signals (Hirschi et al., 1998) and 
direct N-cadherin contacts between endothelial cells and pericytes (Gerhardt et al., 2000).  
The importance of pericytes in stabilizing vessels is evidenced by leaky, heterogeneous 
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tumor blood vessels, which have incomplete pericyte coverage (Abramsson et al., 2002; 
Eberhard et al., 2000; Yonenaga et al., 2005), as well as microvascular defects in PDGF-
B or PDGF beta-receptor knockout mice due to decreased pericyte recruitment (Enge et 
al., 2002; Leveen et al., 1994; Soriano, 1994).  As such, the majority of efforts to create 
stable vascular networks in engineered tissues now incorporate mural support cells in 
some form.  Dermal fibroblasts seeded on the surface of fibrin gels are used to stimulate 
capillary sprouting from endothelial cell-coated beads into the gels (Nakatsu et al., 2003), 
extending previous work demonstrating stimulation of endothelial tubule formation by 
3T3 fibroblasts (Montesano et al., 1993).  The same endothelial sprouting assay can be 
carried out with mesenchymal stem cells (MSCs) distributed throughout the matrix in 
place of surface-seeded fibroblasts (Ghajar et al., 2006), and these interactions are 
thought to occur primarily through secreted soluble factors.  Others are employing direct 
cell-cell interactions between endothelial and mural cells to stabilize the vasculature in 
implanted tissues.  A recent report demonstrated that MSCs can in fact serve as 
perivascular precursor cells by stabilizing endothelial cell networks implanted in vivo for 
several months (Au et al., 2008), producing similar results as earlier work by this group 
using 10T1/2 pericytes (Koike et al., 2004).  Others have demonstrated the ability of 
neural progenitor cells (Ford et al., 2006) and adipose stromal cells (Traktuev et al., 
2009) to stabilize vessels in vivo.  Perhaps the most intriguing finding relevant to 
vascularizing tissues, though, is the discovery that empty basement membrane “sleeves” 
and accompanying pericytes left behind after vessels regressed in response to inhibition 
of VEGF receptor—a potential anti-tumor treatment—quickly promoted 
revascularization upon withdrawal of the drug (Mancuso et al., 2006).  Endothelial 
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sprouts grew into the basement membrane sleeves and fully revascularized the tumor by 
7 days.  While this study has obvious implications in cancer therapy, it also suggests that 
perhaps ECM secreted by endothelial cells and pericytes can be used to guide and 
vascularize engineered tissues efficiently.  While cell-secreted ECM is one way 
endothelial cells might be regulated mechanically by pericytes, it remains to be seen 
whether other means of interaction, for example pericyte-generated traction transmitted 
through the matrix or alignment of matrix fibers, also have a significant impact on 
endothelial cell behavior. 
 
1.8 Summary 
 
Angiogenesis is tightly regulated by many components of the cellular microenvironment, 
from soluble factors to cell-ECM and cell-cell interactions.  While ECM regulation of 
angiogenesis has become a major topic of interest, it has been difficult to separate effects 
of components of the ECM, including adhesive ligand presentation, mechanical 
compliance, and degradability.  In the following chapters, we use micropatterning and 
synthetic hydrogel tools to control more precisely the interaction between endothelial 
cells and the ECM to study its effect on angiogenesis.  In Chapter 2, we describe the 
effect of quantitative changes in adhesion on angiogenic sprouting and gene expression.  
In Chapter 3, we uncover a mechanistic basis for this effect, demonstrating that Pyk2 is 
responsible for enhanced gene expression and sprouting in limited adhesion contexts.  In 
Chapter 4, we introduce a synthetic PEG hydrogel whose mechanical, adhesive, and 
degradable parameters can be tuned to study their independent effects on angiogenesis, as 
well as to serve as a vascularizable scaffold for applications in tissue engineering. 
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CHAPTER 2 
DECREASED CELL ADHESION PROMOTES 
ANGIOGENESIS 
 
 
 
2.1 Introduction 
 
Angiogenesis, or the development of new capillary blood vessels for tissue 
vascularization, involves a coordinated cascade of numerous cellular processes, including 
the activation of quiescent endothelium leading to degradation of the basement 
membrane and interstitial matrix, initiation of sprouting from existing vessels via cell 
proliferation and migration, and coordinated assembly of cells into branching tubules that 
carry blood (Adams and Alitalo, 2007).  It is therefore not surprising that angiogenesis 
depends on a complex interplay between soluble growth factors and cellular adhesive 
interactions with the ECM.   
While a number of growth factors that promote angiogenesis have been identified, 
the VEGF family is perhaps best described due to its roles in stimulating growth, 
migration, and differentiation of endothelial cells into capillary tubes during both 
developmental and pathological angiogenesis (Ferrara et al., 2003).  Although VEGF is 
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known to stimulate endothelial cell proliferation in a dose-dependent manner (Ferrara and 
Henzel, 1989), it is also known that VEGF levels must be tightly regulated in vivo, as 
both a 50% reduction and a two- to three-fold increase in VEGF expression result in 
embryonic lethality (Carmeliet et al., 1996; Ferrara et al., 1996; Miquerol et al., 2000), 
and changes in the local concentration of VEGF can shift a normal, functional angiogenic 
response to a pathological one with abnormal, leaky vessels (Ozawa et al., 2004).  In 
contrast to the detailed understanding of the contribution of such growth factors to 
angiogenesis, much less is known about how cell adhesion to the ECM, and its many 
complex facets, contributes to the regulation of angiogenesis.   
Cell adhesion involves numerous interrelated steps, including binding of integrin 
receptors to ECM ligands, assembly of focal adhesions, and cytoskeletal reorganization 
as cells extend and spread against the matrix.  Several elegant studies using knockouts or 
blocking antibodies have identified a general role for integrins in angiogenesis 
(Avraamides et al., 2008; Friedlander et al., 1995; Kim et al., 2000; Tanjore et al., 2008; 
Yang et al., 1993) and suggest that there is not one particular integrin that is uniquely 
involved in regulating angiogenesis.  Supporting this general adhesive requirement, 
knockout of numerous cell adhesion-related proteins, including FAK, results in a 
phenotype of embryonic lethality with severe vascular defects (Braren et al., 2006; Shen 
et al., 2005).  Together, these studies clearly show that integrin-mediated adhesion is an 
absolute requirement for angiogenesis.  However, in spite of this evidence, it still remains 
unclear whether more subtle shifts in cell-matrix adhesive interactions might modulate 
angiogenesis.  We could reason that if blocking adhesion prevented angiogenesis, then 
enhancing adhesion would promote it, and limiting adhesion would partially suppress it.  
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Consistent with this model, it has been shown that increasing cell adhesion, by either 
increasing ECM density or the area of cell contact with a substrate, stimulates capillary 
endothelial cell proliferation, one step in the angiogenic process (Chen et al., 1997; 
Ingber, 1990).  However, it has also been reported that decreasing adhesion may enhance 
cell-cell interaction and tubulogenesis, another important component of angiogenesis 
(Dike et al., 1999; Ingber and Folkman, 1989).  Thus, it remains unclear how changes in 
the amount of cell-ECM adhesion might ultimately impact the amount or character of 
angiogenesis.    
In this chapter, we examined how changes in cell-ECM adhesion regulate VEGF-
induced angiogenic sprouting and used gene expression profiling to further describe these 
effects.  We observed enhanced sprouting and expression of genes associated with an 
invasive angiogenic phenotype with decreased adhesion.  We also investigated the 
contributions of other microenvironmental properties—ECM stiffness and cell-cell 
interaction—and observed enhanced angiogenic gene expression with decreased stiffness 
and decreased cell-cell adhesion. 
 
2.2 Materials and Methods 
2.2.1 Cell culture  
Human umbilical vein endothelial cells (HUVEC, provided by Guillermo García-
Cardeña, Harvard University) were cultured in Medium 199 (Lonza) containing 20% 
fetal bovine serum (FBS, Gibco), 100 units/ml penicillin, 100 μg/ml streptomycin, 50 
μg/ml ECGS (Biomedical Technologies Inc.), and 100 μg/ml heparin (Sigma) up to 
passage 7 on gelatin-coated culture surfaces.  Starvation medium consisted of Medium 
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199 with 5% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin.  Human adult 
dermal microvascular endothelial cells (HMVEC-dAd, Lonza) were cultured in EGM-
2MV medium (Lonza).  Starvation medium consisted of EGM-2MV medium containing 
0.5% FBS.  Human recombinant VEGF (R&D Systems) was used at 25 ng/ml unless 
noted otherwise. 
2.2.2 Sprouting assays  
Aortic ring sprouting was carried out as described previously (Aplin et al., 2008; 
Auerbach et al., 2003).   Aortic arches were isolated from 12-day-old white Leghorn 
chick embryos (Charles River SPAFAS, Preston, CT), dissected into 1 mm-long 
segments, and embedded into fibrin gels (human fibrinogen and thrombin from Sigma) of 
defined density.  Gels were maintained in EGM-2 medium (Lonza) and imaged 48 hours 
later on an inverted microscope (Nikon Eclipse TE200) with SPOT RT3 camera 
(Diagnostic Instruments, Inc.).  For high-magnification imaging of endothelial cells in the 
sprouts, aortic rings were incubated with 20 μg/ml rhodamine-labeled lectin (Lens 
culinaris agglutinin; Vector Laboratories) for 30 minutes in EBM-2 prior to embedding.  
After fixation 48 hours later in 4% paraformaldehyde, samples were imaged on an 
inverted microscope (Zeiss Axiovert 200M) using a 40x 1.30 NA, oil immersion 
objective (Zeiss) and Zeiss AxioCam HRm camera.  Samples were imaged in 1 μm-thick 
optical z-sections, which were deconvolved prior to creation of maximum intensity 
projections.  For endothelial spheroid sprouting assays, spheroids of HUVECs were made 
as described previously (Korff and Augustin, 1998).  Briefly, HUVECs were suspended 
in a solution of EGM-2 containing 0.24% methylcellulose (Sigma) and deposited in non-
adherent round-bottom 96-well plates (Nunc) to obtain 800 cells per well.  The resulting 
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spheroids were harvested 20-24 hours later and embedded into fibrin gels of defined 
density.  Cultures were maintained in EGM-2 medium and imaged 24 hours later as 
above.  Sprout lengths for all assays were quantified using Image J software (National 
Institutes of Health). 
2.2.3 Generation of micropatterned and ECM protein-coated substrates 
Micropatterned substrates to control cell adhesion were generated as previously described 
(Tan et al., 2004).  Briefly, stamps containing arrays of squares were generated by casting 
poly(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning) from silicon masters 
patterned by photolithography.  Stamps were immersed for 1 hour in an aqueous solution 
of 20 μg/ml fibronectin (BD Biosciences), rinsed three times in water, and blown dry 
with nitrogen.   They were then placed in conformal contact against UV ozone-treated 
PDMS-coated culture surfaces, which were then blocked with 0.2% Pluronic F127 
(BASF) for 1 hour and rinsed with PBS before cell seeding.  Substrates with different 
densities of adsorbed fibronectin, vitronectin, or laminin were generated by immersing 
PDMS-coated surfaces in the specified concentration of ECM protein for 1 hour, rinsing 
two times in water, blocking in 0.2% Pluronic F127 for 1 hour, and rinsing in PBS before 
cell seeding. 
2.2.4 Generation of polyacrylamide gel substrates 
Polyacrylamide gels were prepared by polymerizing pre-specified concentrations of 
acrylamide and bis-acrylamide to achieve the desired elastic modulus using a standard 
free-radical polymerization with initiators (TEMED and ammonium persulfate) (Yeung 
et al., 2005).  20 μg/ml fibronectin was conjugated to the surface by copolymerization of 
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NHS-acrylate (Sigma) dissolved in toluene on top of the polymerizing acrylamide 
solution as described (Kandow et al., 2007).   
2.2.5 Microarray analysis 
HUVECs were cultured on micropatterned islands (1764μm2) of fibronectin or allowed to 
spread fully for 2 hours and then stimulated with 50ng/ml VEGF or no growth factor for 
18 hours in starvation medium.  Sample RNA from each of 3 replicates was isolated 
using the Qiagen RNeasy Mini Kit and prepared for hybridization to microarrays as 
described in the Affymetrix GeneChip Expression Analysis Technical Manual.  Briefly, 2 
μg of total RNA was converted to first-strand cDNA using Superscript II reverse 
transcriptase primed by a poly(T) oligomer that incorporated the T7 promoter.  Second-
strand cDNA synthesis was followed by in vitro transcription for linear amplification of 
each transcript and incorporation of biotinylated CTP and UTP.  The cRNA products 
were fragmented to 200 nucleotides or less, heated at 99ºC for 5 minutes and hybridized 
for 16 hours at 45ºC to Affymetrix Human Genome U133 Plus 2.0 GeneChip expression 
microarrays.  The microarrays were then washed at low (6X SSPE) and high (100 mM 
MES, 0.1 M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence 
was amplified by adding biotinylated anti-streptavidin and an additional aliquot of 
streptavidin-phycoerythrin stain.  A confocal scanner was used to collect fluorescence 
signal at 3 μm resolution after excitation at 570 nm. The average signal from two 
sequential scans was calculated for each microarray feature.  GCRMA-normalized 
expression data from each microarray were deposited in NCBI’s Gene Expression 
Omnibus and are accessible through GEO Series accession number GSE19098 at the 
following link:  http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19098. 
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2.2.6 Real-time gene expression analysis 
Sample RNA was isolated using the Qiagen RNeasy Micro Kit, then quantified using a 
UV spectrophotometer (Becton Dickinson) at 260 nm and 280 nm.  RNA was then 
reverse-transcribed using M-MLV RT (Invitrogen), and the resulting cDNA was 
amplified using Taqman gene expression assay primers (Applied Biosystems) on an 
Applied Biosystems 7300 real-time PCR instrument.  Gene expression values represent 
ΔΔCt normalized to GAPDH and the indicated spread or high fibronectin density control 
condition in all experiments. 
2.2.7 Quantification of focal adhesions 
Focal adhesions were quantified as previously described (Nelson et al., 2004).  Briefly, 
cells were incubated for 1 minute in ice-cold cytoskeleton buffer (50 mM NaCl, 150 mM 
sucrose, 3 mM MgCl2, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin, and 2 
mM PMSF), followed by 1 minute in cytoskeleton buffer containing 0.5% Triton X-100.  
Detergent-extracted cells were fixed in 4% paraformaldehyde in PBS for 20 minutes, 
blocked in 33% goat serum for 1 hour, and incubated with a primary antibody to vinculin 
(hVin1, Sigma-Aldrich), followed by incubation with Alexa Fluor 594–conjugated 
secondary antibodies (Invitrogen).  Samples were imaged on an inverted microscope 
(Zeiss Axiovert 200M) with a 63x 1.40 NA, oil immersion objective and a Zeiss 
AxioCam HRm camera using Zeiss AxioVision software.  Images were filtered and 
binarized using Matlab, and adhesions over 0.5 μm2 counted toward the overall focal 
adhesion number per cell.  
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2.3 Results  
2.3.1 Decreased fibrin density enhances angiogenic sprouting  
 To begin to explore the effects of modulating cell-ECM adhesion on angiogenic 
sprouting, we adopted a simple but robust assay in which explanted embryonic chick 
aortic arches (E12) are sectioned into rings and embedded into fibrin gels (Aplin et al., 
2008; Auerbach et al., 2003).  In this model, endothelial cells within the aortic tissue 
rapidly invade the surrounding fibrin, forming multicellular, tube-like structures.  To 
examine the effect of changing adhesion, we varied the density of fibrin by polymerizing 
gels with fibrinogen ranging from 2.5 to 20 mg/ml.  There was a gradual increase in 
sprouting with decreasing fibrin density, which plateaued below 5 mg/ml due to the 
mechanical weakness of lower density gels.  By 48 hours the average length of sprouts in 
5 mg/ml fibrin gels was twice that in 20 mg/ml fibrin gels (Fig. 2.1A,C).  Interestingly, 
not just the degree but also the character of sprouting appeared to be modulated by 
adhesion, with longer, more sparsely arranged sprouts in low density fibrin gels 
contrasting shorter, more densely packed sprouts in high density fibrin gels.  Labeling the 
samples with an endothelial cell-specific lectin confirmed that the majority of cells within 
the sprouts were endothelial cells (Fig. 2.1B). 
While the aortic ring assay offered the advantage of recreating in vivo-like 
sprouting supported by mesenchymal cells, this added complexity also made it difficult to 
assess whether the observed adhesion effect could be attributed to a direct interaction 
between the ECM and endothelial cells alone.  To address this, we examined whether 
fibrin density could modulate sprouting from spheroids of pure endothelial cells.  
HUVECs were clustered into multicellular spheroids, embedded into fibrin, and allowed 
to sprout from the spheroids.  Again, we observed significantly enhanced sprouting in 
low density as compared to high density fibrin gels, with longer and more numerous 
sprouts (Fig. 2.1D,E).  Thus, it appears that limited adhesion from decreased matrix 
density enhances angiogenesis. 
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Figure 2.1.  Decreased fibrin density enhances angiogenic sprouting.  (A) Sprouting 
of chick aortic rings embedded in 5 mg/ml (left) versus 20 mg/ml (right) fibrin at 48 
hours, bar = 500 μm. (B) Endothelial cells in sprouts labeled with lectin (red) and 
Hoechst 33342 (blue), bar = 20 μm.  (C) Quantification of average sprout length for chick 
aortic rings in 5 mg/ml versus 20 mg/ml fibrin.  Graph represents means ± SEM over 4 
independent experiments, with each experiment averaged over at least 3 aortic rings.  (D) 
Sprouting of HUVEC spheroids embedded in 5 mg/ml (left) versus 20 mg/ml (right) 
fibrin gels at 24 hours, bar = 100 μm.  (E) Quantification of average sprout length and 
average number of sprouts per spheroid in 5 mg/ml versus 20 mg/ml fibrin.  Graphs 
represent means ± SEM over 4 independent experiments, with each experiment averaged 
over at least 4 spheroids.  *, p < 0.05, as calculated by Student’s t-test. 
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2.3.2 Adhesion regulates the expression of genes associated with angiogenesis  
 Because varying fibrin gel density could alter numerous factors important to 
angiogenesis in addition to cell adhesion, we next examined whether more precise 
methods to limit the degree of cell adhesion could similarly induce an activated 
angiogenic phenotype.  We utilized two approaches to modulate cell-ECM adhesion: one 
involves coating substrates with different densities of fibronectin to control ECM 
availability (Ingber and Folkman, 1989), and the other involves micropatterning 
substrates with different sizes of fibronectin-coated islands to control the physical area of 
cell-ECM contact (Fig 2.2A) (Chen et al., 1997).  We selected adhesive conditions for 
this study in which adhesion would be either maximal or approximately half of maximal, 
as measured by quantification of focal adhesions.  We cultured HUVECs on 
micropatterned islands of fibronectin (1764 μm2, “unspread”) or low density (5 μg/ml) 
fibronectin (average cell spreading area 1750 μm2), as compared to cells allowed to 
spread fully on surfaces coated with high density (20 μg/ml) fibronectin (average area 
3200 μm2, “spread”).  Staining for focal adhesions verified that both unspread cells and 
cells cultured on low density fibronectin had significantly fewer adhesions than spread 
cells (Fig. 2.2B).   
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Figure 2.2.  Use of microcontact printing or fibronectin density to control cell 
adhesion.  (A) Method to control cell spreading by microcontact printing.  (B) Cell 
spreading is controlled by constraining cells to micropatterned islands of fibronectin 
(“unspread,” 1764 μm2 area, high density fibronectin) or reducing fibronectin density, as 
compared to fully spread cells on high density fibronectin (“spread”).  Phase images in 
top row, bar = 50 μm.  Immunofluorescent images in bottom row with vinculin (green) 
and Hoechst 33342 (blue), bar = 20 μm.  The average focal adhesion number per cell is 
quantified for each condition.  Data represent means ± SD (15 cells per condition).  *, p < 
0.05 versus high fibronectin density, as calculated by one-way ANOVA and post-hoc 
Tukey’s HSD test.   
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While these well-defined adhesive contexts offer an approach to isolate the 
specific effects of cell-ECM adhesion, they do not support the complex invasion and 
sprouting behavior observed in the fibrin gels.  As such, to characterize the phenotype of 
endothelial cells cultured on these substrates, we examined global gene expression 
changes by microarray analysis.  HUVECs were cultured on micropatterned islands of 
fibronectin or allowed to spread fully for 2 hours and then stimulated with 50 ng/ml 
VEGF or no growth factor for 18 hours in starvation medium.  ANOVA analysis 
indicated that many genes (1,641 out of 28,970) changed expression at least 2-fold in 
response to changes in adhesion alone (Fig. 2.3A).  In contrast, only a small subset of 
genes (108) was upregulated at least 2-fold in response to VEGF in highly adherent, well-
spread cells, highlighting the dramatic effects of adhesion on global gene expression in 
endothelial cells.  Interestingly, substantially more genes (521) responded to VEGF in 
unspread cells, indirectly hinting at the possibility that the response to VEGF may be 
enhanced in the context of limited cell adhesion.  Among the genes most highly 
upregulated in unspread cells in the presence of VEGF were matrix Gla protein (MGP), 
an insoluble matrix protein that binds vitronectin and regulates arterial calcification (Luo 
et al., 1997; Nishimoto and Nishimoto, 2005); stanniocalcin 1 (STC1), a gene involved in 
endothelial cell migration (Zlot et al., 2003) and highly upregulated in several 
microarrays of angiogenesis (Bell et al., 2001; Gerritsen et al., 2002); RhoGAP6 
(ARHGAP6), a Rho GTPase activating protein; and dickkopf homolog 2 (DKK2), a 
regulator of Wnt signaling (Wu et al., 2000) (Fig. 2.3B). 
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Figure 2.3.  Decreased cell adhesion promotes global upregulation of genes in 
response to VEGF.  (A) HUVECs were cultured in four conditions (spread no VEGF, 
spread with VEGF, unspread no VEGF, unspread with VEGF) for 18 hours, after which 
gene expression was analyzed by microarray.  Pairwise comparison shows of numbers of 
genes changing expression at least 2-fold between the conditions listed.  “Upregulated” 
denotes genes expressed higher in the first condition of each pair, and “downregulated” 
denotes genes expressed higher in the second condition of each pair.  (B) Lists of genes 
most highly up- or down-regulated with changes in spreading in the presence of VEGF, 
as well as in unspread cells with or without exposure to VEGF. 
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Figure 2.4.  Adhesion regulates the expression of genes associated with angiogenesis.  
Heatmap of expression of genes associated with angiogenesis in four conditions (spread 
no VEGF, spread with VEGF, unspread no VEGF, unspread with VEGF) after 18 hours 
of culture.  Heatmap values represent log-transformed ratios of expression in one 
condition to the average expression value over all conditions for a given gene, averaged 
over three replicates.  Genes are clustered based on similarities in expression patterns 
using Ward’s hierarchical clustering method.   
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Importantly, when focusing only on genes previously associated with 
angiogenesis (genes associated with Gene Ontology category of angiogenesis, as well as 
genes previously described to be upregulated in models of angiogenesis (Bell et al., 2001; 
Gerritsen et al., 2002)), a majority were upregulated in unspread cells as compared to 
spread cells (Fig. 2.4).  These upregulated genes primarily belonged to functional 
groupings such as angiogenic growth factor signaling, cell-ECM adhesion and migration, 
cell-cell adhesion, and matrix invasion.  Together, this constellation was representative of 
an activated angiogenic phenotype.  In contrast, genes upregulated in spread cells were 
primarily associated with proliferation.  These results were consistent with previous 
studies demonstrating increased proliferation with greater cell adhesion and spreading 
and increased tubulogenesis with decreased adhesion (Chen et al., 1997; Ingber, 1990; 
Ingber and Folkman, 1989).  We confirmed the expression of several genes by 
quantitative real-time PCR in HUVECs and HMVEC-dAds (Fig. 2.5), including:  Eph 
receptor A7 (EPHA7), a member of the ephrin tyrosine kinase receptor family that, along 
with ephrin ligands, mediate cell-cell communication important for vessel sprouting and 
morphogenesis (Zhang and Hughes, 2006); STC1 (described above); membrane type 1 
MMP (MMP14), a matrix metalloproteinase required for vascular invasion (Collen et al., 
2003; Hiraoka et al., 1998); and cyclin D1 (CCND1), a cyclin required for G1/S 
progression in the cell cycle known to regulate endothelial cell proliferation (Yasui et al., 
2006).  We observed a similar expression pattern in cells cultured on high versus low 
densities of fibronectin (Fig. 2.6A), as well as on high and low densities of vitronectin 
and laminin (Fig. 2.6B) to confirm the effect was not restricted to fibronectin.  These 
results demonstrate that limiting cell adhesion through multiple mechanisms, whether via 
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changes in ligand density or cell spreading, induced the expression of genes associated 
with the invasive processes of angiogenesis, and were consistent with our observations of 
enhanced sprouting in lower density fibrin gels. 
In addition to cell adhesion, we investigated the roles of other 
microenvironmental properties that could impact angiogenic sprouting—matrix stiffness 
and cell-cell interaction—in regulating angiogenic gene expression.  Using fibronectin-
coupled polyacrylamide gels to vary stiffness, we observed increased angiogenic gene 
expression in cells cultured on soft versus stiff substrates (Fig. 2.7A), which is also 
consistent with enhanced sprouting in lower density fibrin gels.  This result could signify 
an important independent role of ECM stiffness in regulating gene expression or result 
from changes in cell spreading and adhesion signaling in soft versus stiff conditions.  To 
examine the role of cell-cell contact, we measured gene expression in confluent 
endothelial cells compared to single endothelial cells of similar spread areas.  While we 
observed high gene expression in single endothelial cells cultured in limited adhesive 
contexts, this response was inhibited in confluent endothelial cells (Fig. 2.7B).  This 
result suggests an important role for cell-cell adhesion in regulating gene expression and 
could potentially explain differences in behavior between quiescent endothelial cells in 
monolayers versus actively sprouting cells. 
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Figure 2.5.  Confirmation of gene expression in HUVECs and HMVECs.  HUVECs 
(A) and HMVEC-dAds (B) were cultured as spread or unspread, in starvation medium 
with or without 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select 
genes by quantitative real-time PCR analysis (EPHA7 = Eph Receptor A7, MMP14 = 
Membrane type 1 MMP, STC1 = Stanniocalcin 1, CCND1 = Cyclin D1).  Data represent 
means ± SEM (n ≥ 3).  *, p < 0.05 compared to the spread condition, and +, p < 0.05 
compared to no VEGF control, as calculated by two-way ANOVA and post-hoc Tukey’s 
HSD test.  #, p < 0.05 compared to the spread condition, as calculated by Student’s t-test 
(not significant by ANOVA). 
 
 
 
Figure 2.6.  Decreased ECM ligand density promotes the expression of genes 
associated with angiogenesis.  (A) HUVECs were cultured on high (20 μg/ml) or low (5 
μg/ml) density fibronectin, in starvation medium with or without 25 ng/ml VEGF for 16-
18 hours and analyzed for expression of select genes by quantitative real-time PCR 
analysis.  Data represent means ± SEM (n = 3).  (B) HUVECs were cultured on high (20 
μg/ml) or low (5 μg/ml) density fibronectin, vitronectin, or laminin, in starvation medium 
containing 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select genes 
by quantitative real-time PCR analysis.  Data represent means ± SEM (n = 3).   
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 Figure 2.7.  Decreased ECM stiffness and cell-cell contact promote the expression of 
genes associated with angiogenesis.  (A) HUVECs were cultured on soft (400 Pa) and 
stiff (5 kPa) fibronectin-coupled polyacrylamide gels, in starvation medium with or 
without 25 ng/ml VEGF for 16-18 hours and analyzed for expression of select genes by 
quantitative real-time PCR analysis.  Data represent means ± SEM (n = 3).  *, p < 0.05 
compared to the 5 kPa condition, and +, p < 0.05 compared to no VEGF control, as 
calculated by two-way ANOVA and post-hoc Tukey’s HSD test.   (B) HUVECs were 
cultured as spread, unspread, or confluent, in starvation medium with or without 25 ng/ml 
VEGF for 16-18 hours and analyzed for expression of select genes by quantitative real-
time PCR analysis.  Data represent means ± SEM (n = 3).  *, p < 0.05 compared to the 
unspread condition, and +, p < 0.05 compared to no VEGF control, as calculated by two-
way ANOVA and post-hoc Tukey’s HSD test.   
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2.4 Discussion   
The role of multiple adhesive states in angiogenesis 
 Previous studies have demonstrated enhanced endothelial cell proliferation with 
increased cell spreading and ECM density (Chen et al., 1997; Ingber, 1990), and 
inhibition of either endothelial proliferation or cell-ECM adhesion are proven mainstay 
strategies for developing anti-angiogenic therapies (Avraamides et al., 2008; Ferrara and 
Kerbel, 2005).  As a result, it has largely been assumed that angiogenesis would be 
optimal in highly adhesive contexts.  It was therefore unexpected that we initially 
observed a role for limited adhesion in promoting capillary sprouting.  Previous reports 
had described increased tubulogenesis with limited cell adhesion and spreading in vitro in 
assays reminiscent of vasculogenesis (Dike et al., 1999; Ingber and Folkman, 1989), but 
the relevance of these findings to angiogenesis had remained unclear.  Interestingly, here 
we revealed that this limited adhesion context drives sprouting in part by stimulating an 
activated endothelial phenotype associated with vascular invasion and remodeling, which 
can now be characterized by a specific gene expression profile.  It has recently been 
shown that increasing matrix compliance, which in other studies is thought to suppress 
integrin activation (Paszek et al., 2005), appears to enhance VEGF responsiveness of 
endothelial cells and angiogenesis in vivo (Mammoto et al., 2009).  Another recent study 
has also reported that low concentrations of integrin antagonists, under development as 
anti-angiogenic cancer therapeutics, actually promote angiogenesis (Reynolds et al., 
2009).  Our studies here point to one mechanism by which both the matrix compliance 
and integrin antagonist effects could be explained.   
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The fact that differences in the degree of cell-ECM adhesion could promote 
distinct (proliferative versus invasive) endothelial cell behaviors important for 
angiogenesis may have implications in numerous settings.  Because angiogenesis is a 
complex, multi-step process, it is possible that these different cellular behaviors are 
stimulated in different stages of angiogenesis: enhanced MMP production and ECM 
degradation at the sprouting tips (Yana et al., 2007) could limit adhesion and thereby 
promote migration and cellular invasion, and increased ECM deposition along the stalks 
could be responsible for the observed proliferation in these regions (Gerhardt et al., 
2003).  Notably, our microarray analysis identified upregulation of genes associated with 
tip cells—VEGFR-2/KDR, PDGF-B, and MT1-MMP/MMP14 (Gerhardt et al., 2003; 
Yana et al., 2007)—in cells with limited adhesion exposed to VEGF, suggesting that 
adhesive gradients may indeed play an important role in dictating the diverse cell 
behaviors that are coordinated along angiogenic sprouts.  Extending these implications to 
the pathologic settings of matrix-dense tumors and fibrotic tissue, it is possible that the 
altered degree of adhesive interactions may contribute to the abnormal angiogenesis in 
these settings as much as excessive soluble growth factor stimulation, which is widely 
cited as a key promoter of pathological angiogenesis (Carmeliet, 2005; Ozawa et al., 
2004).  Thus, while it has previously been shown that integrins and integrin-mediated 
adhesion are required for angiogenesis, the data presented here suggest a substantially 
more subtle interplay between changes in the degree of adhesion and endothelial cell 
phenotypes, which likely contributes to the complex staging of multiple behaviors 
necessary to generate new capillary beds.    
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CHAPTER 3   
PYK2 MEDIATES ANGIOGENESIS PROMOTED BY 
LIMITED ADHESION 
 
 
 
3.1 Introduction 
 
To determine a mechanistic basis for the enhanced gene expression and sprouting 
observed in limited adhesive contexts in Chapter 1, we examined the roles of several 
molecules known to transduce adhesion signals—including ERK, ROCK, Src family 
kinases, and FAK.  Integrins signal through molecules such as Src and FAK, which aid in 
focal contact turnover required for cell migration and invasion (Stupack and Cheresh, 
2004).  FAK is required for embryonic vascular development in vivo (Braren et al., 2006; 
Shen et al., 2005), and its coupling to integrin αvβ5 by Src is critical for VEGF signaling 
in endothelial cells and activates the Ras-Raf-ERK pathway downstream (Eliceiri et al., 
2002).  ERK signaling promotes proliferation, survival, and migration of endothelial cells 
(Stupack and Cheresh, 2004), and sustained ERK activation by growth factors has been 
shown to require integrin ligation and is required for in vivo angiogenesis (Eliceiri et al., 
1998; Perruzzi et al., 2003; Stupack and Cheresh, 2004).  RhoA signaling has been shown 
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to be essential for VEGF-induced in vivo angiogenesis and in vitro endothelial cell 
migration and capillary morphogenesis (Bryan and D'Amore, 2007; van Nieuw 
Amerongen et al., 2003).  While most of these molecules did not appear to play a 
significant role in regulating gene expression promoted by limited adhesion, we did find 
that Pyk2 (also known as RAFTK, CAK-β, or CADTK), a FAK family non-receptor 
tyrosine kinase, regulates both gene expression and endothelial sprouting through its 
enhanced activation by VEGF in limited adhesion conditions. 
Further downstream, we sought to identify transcription factors that might be 
responsible for regulating the gene expression patterns observed.  We used CARRIE 
analysis to identify several transcription factors, including STAT5 (A and B), heat shock 
factor 1 and 2, hepatic nuclear factor 1, and cMyc/Max, that may be important in 
regulating gene expression responses to changes in cell adhesion and VEGF exposure.   
 
 
3.2 Materials and Methods 
 
All cells, culture substrates, sprouting assays, and real-time gene expression analyses 
were used or conducted as in Chapter 2. 
3.2.1 Reagents 
The MEK inhibitor U0126 (Calbiochem), ROCK inhibitor Y-27632 (Tocris), and Src 
family kinase inhibitor PP2 (Calbiochem) were all used at 10 μM.  The FAK inhibitor 
PF-573228 (Tocris Bioscience) and Pyk2 inhibitor PF-0494755 (gift, Leonard 
Buckbinder, Pfizer) were used at 500 nM unless noted otherwise.  Adenoviruses 
harboring GFP, FRNK, and wild-type FAK were generated as described previously 
(Pirone et al., 2006).  Adenoviruses for expression of β-galactosidase (control) and Pyk2 
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shRNA, as well as wild-type Pyk2 were provided by Leonard Buckbinder (Pfizer, 
Groton, CT).  Cells were infected with β-gal and Pyk2 shRNA adenoviruses at a MOI of 
200.   
3.2.2 Immunoblotting 
Cells were rinsed in PBS and lysed in ice-cold RIPA buffer (1% Triton X-100, 150 mM 
sodium chloride, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, 1 mM 
sodium orthovanadate, 5% (v/v) β-mercaptoethanol, and 1 μg/ml each aprotinin, 
leupeptin, pepstatin, and PMSF).  Proteins were separated by SDS-PAGE, transferred to 
PVDF membranes, and blocked with 5% BSA or 5% milk in TBS-T as recommended for 
each antibody.  Blots were probed with antibodies against total FAK (clone 77, BD 
Biosciences), phosphorylated FAK (Y397, Biosource), FRNK (06-543, Millipore), total 
Pyk2 (clone 11, BD Biosciences), phosphorylated Pyk2 (Y402, Biosource), and GAPDH 
(clone 6C5, Ambion), followed by horse radish peroxidase-conjugated secondary 
antibodies (Jackson ImmunoResearch) and SuperSignal West Dura chemiluminescent 
detection (Pierce).  Densitometric analysis was performed using a VersaDoc digital 
imaging system with QuantityOne software (BioRad).  
 
 
3.3 Results 
3.3.1 FAK and Src family kinases may regulate limited adhesion-induced angiogenic 
gene expression; ERK and ROCK are not major regulators of gene expression 
To study the roles of ERK, ROCK, FAK, and Src family kinases in mediating 
limited adhesion-induced gene expression, we cultured HUVECs in spread or unspread 
conditions in the presence of VEGF and either the MEK inhibitor U0126, the ROCK 
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inhibitor Y-27632, the FAK inhibitor PF-573228 (“PF228”), or the Src family kinase 
inhibitor PP2 for 16-18 hours and analyzed for gene expression.  ERK and ROCK 
inhibition had no significant effect on gene expression in either spread or unspread cells 
(Fig. 3.1A,B).  FAK and Src family kinase inhibition, however, did result in a decrease in 
gene expression in unspread cells (Fig. 3.1C,D).  These results suggest that signals from 
cell adhesion to integrins, as opposed to cytoskeletal tension, are primarily responsible 
for the VEGF-induced gene expression observed.  Given the difficulty of studying and 
determining the individual roles of members of the Src family kinases, we decided to 
explore further the role of FAK in regulating angiogenic gene expression.   
 Figure 3.1.  FAK and Src family kinases may regulate limited adhesion-induced 
angiogenic gene expression; ERK and ROCK are not major regulators of gene 
expression.  Gene expression of HUVECs after 16-18 hours of culture in spread or 
unspread conditions with or without VEGF stimulation and 10 μM U0126 (A), 10 μM Y-
27632 (B), 5 μM PF228 (C), or 10 μM PP2 (D). 
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3.3.2 FAK is not a major regulator of limited adhesion-induced angiogenic gene 
expression 
 To investigate the role of FAK in VEGF-induced gene expression more 
specifically, we expressed wild-type FAK or FRNK, the dominant-negative C-terminal 
fragment of FAK, in HUVECs using recombinant adenoviruses and confirmed that these 
treatments increased or decreased FAK signaling, respectively (Fig. 3.2A).  FAK-, 
FRNK-, and control GFP-expressing cells were cultured in spread or unspread conditions 
with or without VEGF exposure for 16-18 hours and analyzed for gene expression.  
While expression of FAK and FRNK had no significant effect on the expression of 
CCND1 and EPHA7 in all adhesive and soluble contexts, FRNK expression did rescue 
VEGF-induced STC1 expression in spread cells to levels greater than in control unspread 
cells (Fig. 3.2B).  This isolated result provided a faint suggestion that the absence of FAK 
signaling—whether through decreased adhesion or expression of FRNK—may promote 
the expression of some genes associated with angiogenesis.  However, in general, FAK 
did not appear to explain many of our observations.   
 Figure 3.2.  FAK is not a major regulator of limited adhesion-induced angiogenic 
gene expression.  (A) Western blot of phospho-Y397-FAK, total FAK, FRNK, phospho-
Y402-Pyk2, total Pyk2, and GAPDH in GFP-, FAK-, and FRNK-overexpressing 
HUVECs on both high (20 μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces.  
(B) Gene expression of GFP-, FRNK-, and FAK-overexpressing HUVECs after 16-18 
hours of culture in spread or unspread conditions with or without VEGF stimulation.  
Data represent means ± SEM (n = 3).  *, p < 0.05 compared to GFP, as calculated by 
three-way ANOVA and post-hoc Tukey’s HSD test.   
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3.3.3 Pyk2 regulates the expression of genes associated with angiogenesis 
 The discrepancy in results between the pharmacological FAK inhibitor and FAK 
and FRNK adenoviruses can likely be explained by the lack of specificity of the inhibitor 
at the dose used (5 μM) in the previous experiments.  Indeed, at that dose, the inhibitor 
also targets a structurally related homologue of FAK, Pyk2.  While endothelial cell-
specific knockout of FAK has been shown to be embryonic lethal (Braren et al., 2006; 
Shen et al., 2005), inducible knockout of FAK in adult endothelial cells does not affect 
angiogenesis due to a compensatory upregulation of Pyk2 (Weis et al., 2008).  Pyk2 is 
activated by a number of extracellular signals, including growth factors and ECM 
adhesion (Lev et al., 1995; Zheng et al., 1998).  However, unlike FAK, which is 
ubiquitously expressed, Pyk2 is restricted to primarily hematopoietic and neuronal 
tissues, with upregulation in a broader group of tissues later in development (Avraham et 
al., 1995; Sasaki et al., 1995), and thus its role in angiogenesis is poorly understood.  In 
addition to its compensatory role for FAK in adult angiogenesis, Pyk2 has been shown to 
be involved in endothelial cell spreading and migration (Avraham et al., 2003), VE-
cadherin-mediated cell-cell adhesion (van Buul et al., 2005), and neovessel formation 
(Matsui et al., 2007; Tang et al., 2002).  However, the effect of different adhesive 
contexts on its role in angiogenesis has not been explored.   
To investigate the role of Pyk2 in regulating angiogenic gene expression in 
different adhesive contexts, we first knocked down expression of Pyk2 using a targeted 
shRNA (Fig. 3.3A) and cultured Pyk2 and control (β-gal) shRNA-expressing HUVECs in 
spread or unspread conditions with or without VEGF exposure for 16-18 hours.  Pyk2 
knockdown led to a significant decrease in the expression of EPHA7 and STC1 in 
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unspread cells exposed to VEGF, to levels similar to wild type spread cells stimulated 
with VEGF (Fig. 3.3B).  In order to obtain a broader understanding of the importance of 
Pyk2 in angiogenic gene expression, we screened numerous additional genes associated 
with angiogenesis that were upregulated by VEGF and/or limited adhesion and found that 
many but not all appeared to be suppressed with Pyk2 knockdown (Fig. 3.3C). 
While these data suggest that Pyk2 is necessary for VEGF-induced gene 
expression in limited adhesive contexts, it is not clear whether Pyk2 activity is sufficient 
for controlling angiogenic gene expression.  To address this possibility, we overexpressed 
wild-type Pyk2 (Fig. 3.4A) and placed cells in high versus low adhesive contexts, with 
and without VEGF stimulation.  Although Pyk2 alone could not initiate angiogenic gene 
expression, it rescued EPHA7 and STC1 expression in fully spread cells in response to 
VEGF (Fig. 3.4B), indicating Pyk2 was necessary and sufficient for transducing the low 
adhesive context that supports VEGF responsiveness.  Interestingly, CCND1 expression 
was not affected by Pyk2 manipulation, suggesting that only genes normally upregulated 
by decreased adhesion and associated with an activated endothelial phenotype—and not 
those associated with proliferation—are regulated by Pyk2.   
 One mechanism by which Pyk2 might promote gene expression only in limited 
adhesive contexts is if limited cell-ECM adhesion rendered Pyk2 more responsive to 
soluble VEGF stimulation than highly adhesive conditions.  To explore this possibility, 
we measured Pyk2 activity in response to VEGF in HUVECs cultured on high and low 
densities of fibronectin.  We observed two-fold greater activity in cells cultured on low 
density versus high density fibronectin (Fig. 3.5), confirming that reduced adhesion in 
fact enhances Pyk2 activation by VEGF. 
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Figure 3.3.  Pyk2 knockdown inhibits the expression of genes associated with 
angiogenesis.  (A) Expression of Pyk2 mRNA in spread versus unspread HUVECs 
transfected with control (β-gal) versus Pyk2 shRNA.  Data represent means ± SEM (n = 
4).  *, p < 0.05, as calculated by three-way ANOVA and post-hoc Tukey’s HSD test.  (B) 
Gene expression of HUVECs transfected with control versus Pyk2 shRNA after 16-18 
hours of culture in spread or unspread conditions with or without VEGF stimulation.  
Data represent means ± SEM (n = 3).  *, p < 0.05, as calculated by three-way ANOVA 
and post-hoc Tukey’s HSD test.  (C) Additional genes associated with angiogenesis that 
were upregulated by limited adhesion, VEGF stimulation, or both are shown as 
suppressed or not suppressed by Pyk2 knockdown, as measured by real-time PCR. 
 Figure 3.4.  Pyk2 overexpression rescues the expression of genes associated with 
angiogenesis.  (A) Western blot of phospho-Y402-Pyk2, total Pyk2, phospho-Y397-
FAK, total FAK, and GAPDH in GFP- and Pyk2-overexpressing HUVECs on both high 
(20 μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces.  (B) Gene expression 
of GFP- and Pyk2-overexpressing HUVECs after 16-18 hours of culture in spread or 
unspread conditions with or without VEGF stimulation.  Data represent means ± SEM (n 
= 3).  #, p < 0.05, as calculated by Student’s t-test (not significant by ANOVA).   
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Figure 3.5.  VEGF-induced Pyk2 activity is increased by limited adhesion.  Western 
blot of phospho-Y402-Pyk2, total Pyk2, and GAPDH in HUVECs cultured on high (20 
μg/ml) and low (5 μg/ml) density fibronectin-coated surfaces with or without VEGF 
stimulation.  Graph shows quantification of 4 independent experiments, where data 
represent means ± SEM and *, p < 0.05, as calculated by two-way ANOVA and post-hoc 
Tukey’s HSD test. 
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3.3.4 Pyk2 regulates angiogenic sprouting in low adhesion conditions 
 Our studies uncovered a role for Pyk2 in regulating the expression of several 
genes involved in angiogenesis.  However, it remained unclear whether these effects on 
gene expression would ultimately impact the physical process of angiogenic sprouting.  
To investigate this possibility, we examined whether Pyk2 manipulation would impact 
sprouting from endothelial spheroids in high and low density fibrin gels.  We also 
compared the effects of FAK manipulation to confirm whether its effects on sprouting are 
consistent with the minimal role for FAK we observed in the gene expression studies.  
Unfortunately, adenoviral infection of the HUVECs appeared to alter their ability to form 
the tightly packed spheroids required in this assay, so we inhibited Pyk2 with the 
pharmacological inhibitor PF-04594755 (“PF755” (Bonnette et al.)) and FAK with the 
pharmacological inhibitor PF228, choosing concentrations based on maximal inhibition 
of the target kinase and minimal inhibition of the other (Fig. 3.6A,B).  Pyk2 inhibition 
with 500 nM PF755 significantly decreased sprouting in low density gels compared to 
controls but had no effect on sprouting in high density gels, consistent with a specific role 
for Pyk2 in low adhesion-induced angiogenesis.  FAK inhibition with 500 nM PF228 had 
no significant effect, and Pyk2 and FAK inhibition together had the same effect as Pyk2 
inhibition alone (Fig. 3.7A,B), suggesting a minimal role for FAK in these studies.  
Similarly, sprouting from chick aortic rings was significantly reduced with PF755, 
although FAK inhibition with PF228 also inhibited sprouting in low density gels but to a 
lesser extent, and the two inhibitors together resulted in a synergistic reduction of 
sprouting (Fig. 3.8A,B).  The reduction of sprouting by FAK inhibition in aortic rings but 
not pure endothelial spheroids raises a possibility that the inhibitor is targeting supporting 
mesenchymal cells as opposed to the endothelium.  Taken together, these results mirror 
gene expression patterns in that inhibition of Pyk2 reduces sprouting in limited adhesive 
conditions to levels similar to those in high adhesive conditions, thus demonstrating a 
role for Pyk2 in transducing limited adhesive signals to promote angiogenic gene 
expression and sprouting.   
 
Figure 3.6.  Dosing of FAK and Pyk2 inhibitors.  FAK and Pyk2 phosphorylation in 
HUVECs in response to 0, 0.1, 0.5, or 1 μM of PF-573228 (“PF228,” FAK inhibitor) (A) 
or PF-04594755 (“PF755,” Pyk2 inhibitor) (B).  Graphs show quantification of FAK and 
Pyk2 activity (ratio of phosphorylated to total protein), normalized to DMSO (no drug) 
control.   
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 Figure 3.7.  Pyk2 regulates endothelial spheroid sprouting in low adhesion 
conditions.  (A) Sprouting of HUVEC spheroids in the presence of 500 nM of PF228, 
PF755, or both in combination as compared to DMSO control in low (5 mg/ml) versus 
high (20 mg/ml) density fibrin.  Bar, 100 μm.  (B) Quantification of average sprout length 
and sprout number over 4 independent experiments, with each experiment averaged over 
at least 3 spheroids.  Data represent means ± SEM.  *, p < 0.05 versus DMSO control, as 
calculated by one-way ANOVA and post-hoc Tukey’s HSD test.  #, p < 0.05 versus 
DMSO control, as calculated by Student’s t-test (not significant by ANOVA). 
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Figure 3.8.  Pyk2 regulates ex vivo sprouting in low adhesion conditions.  (A) 
Sprouting of aortic rings in the presence of 500 nM of PF228, PF755, or both in 
combination as compared to DMSO control in low (5 mg/ml) versus high (10 mg/ml) 
density fibrin.  Bar, 300 μm.  (B) Quantification of average sprout length over 3 
independent experiments, with each experiment averaged over at least 2 aortic rings.  
Data represent means ± SEM.  *, p < 0.05, as calculated by one-way ANOVA and post-
hoc Tukey’s HSD test.   
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3.3.5 Transcription factors regulating gene expression patterns 
Downstream of Pyk2, we sought to identify transcription factors that might be 
responsible for regulating gene expression in response to changes in cell adhesion.  We 
used CARRIE analysis, which identifies from microarray data both transcription factors 
that change expression in response to a stimulus and those whose binding sites are over-
represented in the promoter regions of the group of genes responding to the stimulus 
(Haverty et al., 2004).  We identified several transcription factors, including STAT5 (A 
and B), heat shock factor 1 and 2, hepatic nuclear factor 1, and cMyc/Max (Fig. 3.9), that 
may be important in regulating gene expression responses to changes in cell adhesion and 
VEGF exposure.  While we have not yet investigated these factors in depth, 
JAK/STAT5A has been shown to be activated by integrin-mediated cell adhesion (Brizzi 
et al., 1999) and VEGF (Dudley et al., 2005) in endothelial cells and so could be an 
important regulator of gene expression in our system. 
 
  
Figure 3.9.  Transcription factors identified by CARRIE analysis as potential 
regulators of adhesion-sensitive genes.  Lists of transcription factors identified by 
CARRIE analysis as potential regulators of gene expression changes between spread and 
unspread cells with and without VEGF stimulation.  Lists represent top 10 transcription 
factors identified by ROVER analysis, with accompanying ROVER p-value. 
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3.4 Discussion   
The roles of Pyk2 versus FAK in angiogenesis 
 Previous studies have suggested that FAK and Pyk2 have overlapping and 
redundant functions in regulating angiogenesis.  While the endothelial-specific FAK 
knockout is embryonic lethal (Braren et al., 2006; Shen et al., 2005), conditional 
knockout in adults results in no abnormal phenotype due to a compensatory mechanism 
in which Pyk2 upregulation rescues angiogenesis (Weis et al., 2008).  Interestingly, while 
Pyk2-null mice have no overt developmental vascular defects, hindlimb reperfusion after 
ischemia is impaired, and Pyk2-null endothelial cell migration and tubulogenesis are 
defective (Matsui et al., 2007).  The importance of Pyk2 only in adult angiogenesis could 
be explained by its lack of expression in embryonic endothelium (Avraham et al., 1995), 
whereas FAK is always expressed.  Our results indicate FAK and Pyk2 may be 
responsible for different aspects of angiogenesis depending on the adhesive context.  We 
show that Pyk2 activity is upregulated with decreased adhesion and that it is responsible 
for promoting angiogenic gene expression and sprouting in limited adhesive contexts.  In 
contrast, FAK activity is increased with greater cell adhesion and spreading (Guan et al., 
1991; Pirone et al., 2006), has little effect on modulating the expression of angiogenic 
genes associated with endothelial invasion and migration, but appears to be important for 
regulating endothelial cell proliferation (Gilmore and Romer, 1996; Pirone et al., 2006).  
Thus, FAK and Pyk2 may be responsible for differences in the regulation and character 
of angiogenesis in developmental versus adult settings as well as in high versus low 
density matrices.  This balance between the two homologues may even explain observed 
differences in endothelial cell behaviors within a single angiogenic sprout as a result of 
local gradients in the adhesive cues present, in which cells in the stalk are surrounded by 
a more developed ECM and proliferate while cells at the tip are degrading ECM and 
taking on a more invasive phenotype (Fig. 3.10).   
 
 
 
Figure 3.10.  Proposed model of adhesive regulation of angiogenesis mediated by 
Pyk2 and FAK.  In relatively low adhesion contexts, Pyk2 activity is high, promoting 
sprouting and expression of genes associated with an invasive angiogenic phenotype in 
response to VEGF.  In contrast, FAK activity is high in relatively high adhesion contexts, 
promoting cell survival and proliferation, as well as vascular stability. 
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Although FAK and Pyk2 are homologues with some structural and sequence 
similarity, they have distinct characteristics that could explain their individual functions 
in the context of angiogenesis.  The increase in Pyk2 activity with decreased adhesion 
could potentially result from a direct competition with binding partners of FAK.  
Adhesion is thought to increase FAK signaling in part by co-localizing FAK signaling 
partners to assembling focal adhesions (Parsons, 2003).  Pyk2, with its more cytoplasmic 
distribution as compared to FAK (Zheng et al., 1998), may therefore better access 
upstream and downstream signaling partners when they are not sequestered into focal 
adhesions.  Elucidating how the activation of Pyk2 then regulates invasive angiogenic 
genes while FAK regulates proliferative genes is an important direction for future studies.   
Here, we report a role for limited endothelial adhesion in promoting an invasive 
angiogenic gene expression profile and capillary sprouting, and demonstrate that Pyk2 
plays a critical role in mediating these effects.  These findings further suggest the 
existence of a balance between invasive and proliferative phenotypes regulated by cell 
adhesion, which is potentially mediated by a balance between Pyk2 and FAK signaling.   
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CHAPTER 4 
REGULATION OF ANGIOGENESIS BY TUNABLE 
POLY(ETHYLENE GLYCOL) HYDROGELS 
 
 
 
4.1 Introduction 
 
A major goal of understanding how the ECM regulates angiogenesis is to apply 
this knowledge toward engineering materials to promote vascularization for tissue 
engineering and therapeutic angiogenesis.  Synthetic materials including hydrogels have 
been instrumental in furthering this goal given their biocompatibility and non-
immunogenicity, as well as more control over material parameters such as compliance, 
adhesive ligand density and type, and porosity (Lutolf and Hubbell, 2005).   
 PEG hydrogels are widely used in tissue engineering applications and serve as a 
simple platform onto which various biological functionalities can be incorporated to 
mimic the native cellular microenvironment.  PEG itself resists protein adsorption 
(Gombotz et al., 1991), so cells can only interact with it through covalently crosslinked 
oligopeptides such as RGD that represent integrin binding regions within native ECM 
proteins (Hern and Hubbell, 1998).  MMP-sensitive sequences can also be incorporated 
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into the PEG backbone to render the material degradable by cellular proteases (Lutolf et 
al., 2003a; Lutolf et al., 2003b; Mann et al., 2001a).  The mechanical properties of PEG 
hydrogels can be varied through either crosslinking density or chain length between 
crosslinks.  All of these properties are significant given the importance of adhesive ligand 
density and type, MMP degradation, and mechanical compliance on angiogenesis.  
Further, the modular synthetic scheme allows us to begin to explore the roles of 
individual parameters in angiogenesis independent of others. 
While most studies of angiogenesis are undertaken in native ECMs such as fibrin, 
collagen, or Matrigel, several recent studies have made use of PEG hydrogels and their 
versatile chemical modifications.  PEG hydrogels containing covalently immobilized 
VEGF (Leslie-Barbick et al., 2009) and VEGF released by cell-mediated proteolytic 
degradation (Zisch et al., 2003) demonstrated enhanced endothelial tubulogenesis and 
vascular invasion.  Covalent incorporation of ephrin A1, a cell-cell adhesion molecule 
important in regulating vascular guidance and assembly, promoted endothelial cell 
adhesion and tubule formation (Moon et al., 2007), and immobilizing the cell-adhesive 
peptide RGDS in patterns of lines on the surface of PEG hydrogels identified an 
intermediate width ideal for formation of endothelial cords (Moon et al., 2009), 
consistent with previous results demonstrating enhanced tubulogenesis on fibronectin 
lines of intermediate width (Dike et al., 1999; Ingber and Folkman, 1989).   
In this chapter, we began to explore ECM parameters promoting optimal 
vascularization, including degradability, adhesive ligand density, and mechanical 
compliance, using PEG hydrogels.  We also made use of our ability to vary parameters 
independently in these hydrogels to study the interaction between mechanical compliance 
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and adhesive ligand density in regulating angiogenesis.  For these studies, we used the 
step-growth polymerization of bis-cysteine MMP-sensitive peptides and PEG-diacrylate 
(PEGDA) or PEG-diacrylamide (PEGDAAm) to make high molecular weight 
photoactive macromers.  These macromers were then crosslinked along with cell-
adhesive acrylate-PEG-CRGDS into hydrogels during a second radical-mediated 
photopolymerization step.  Resultant hydrogels were characterized for MMP 
susceptibility, cell adhesion, and mechanical compliance and then assessed for 
angiogenic potential with an ex vivo chick aortic arch assay. 
 
4.2 Materials and Methods 
4.2.1 Reagents and cell culture 
All reagents were from Sigma-Aldrich (St. Louis, MO) and were used as received unless 
otherwise described. Acryloyl chloride was from Alfa Aesar (Ward Hill, MA). Culture 
media and human umbilical vein endothelial cells (HUVECs) were from Lonza (Basel, 
Switzerland), and were maintained in complete Endothelial Growth Medium-2 (EGM-2, 
Lonza).  
4.2.2 Synthesis and characterization of poly(ethylene glycol) diacrylate (PEGDA) 
Dry poly(ethylene glycol) (PEG; molecular weight (MW) 3400 or 6000) was acrylated by 
reaction with triethylamine (TEA; clear, colorless, 2 molar excess to PEG) and acryloyl 
chloride (clear, colorless, 4 molar excess to PEG) in anhydrous dichloromethane (DCM) 
under argon as described previously (Mann et al., 2001a). Yields were typically in the 
range 80-90% (~120 g), and percent acrylation was 99% as verified by 1H NMR for the 
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characteristic peak (4.32 ppm) of the PEG methylene protons adjacent to the acrylate 
(Mann et al., 2001a). 
4.2.3 Synthesis and characterization of poly(ethylene glycol) diacrylamide 
(PEGDAAm) 
PEGDAAm was synthesized similar to a protocol described previously (Gobin and West, 
2002; Mann et al., 2001a; West and Hubbell, 1999) by taking PEG through a dimesylate, 
and then a diamine, before arriving at the diacrylamide.  To a solution of dry PEG (MW 
3400, 140 g, 0.0412 mol) and 4-dimethylaminopyridine (DMAP, 0.1 molar equivalent to 
mesyl chloride, .0247 moles, 3.0183 g) in anhydrous dichloromethane (DCM, 150 mL) 
under argon was added anhydrous triethylamine (TEA, 6 molar excess to PEG, 34.4 mL, 
0.2471 mol). After mixing for 10 minutes, a concentrated solution of mesyl chloride 
(MsCl, 6 molar excess to PEG, 19.1 mL, 0.2471 mol) in DCM was added dropwise with 
rapid stirring. The reaction proceeded overnight under argon. PEG dimesylate was 
purified by filtering the solution through filter paper under vacuum, followed by 
precipitation in diethyl ether (1 L). The product was again filtered and dried under 
vacuum to yield PEG dimesylate. To synthesize PEG diamine from PEG dimesylate, the 
entire PEG dimesylate product was added to 800 mL 25% aqueous ammonia solution 
within 2 days of completing the previous reaction. The container was closed and sealed 
tightly with Parafilm, and the reaction proceeded for 4 days with vigorous stirring at 
room temperature. The container was then opened to atmosphere to allow the ammonia to 
evaporate over 3 days. To remove remaining ammonia, NaOH was used to raise the pH 
of the solution to 13, and the solution was extracted with DCM (1:5 DCM volume to 
ammonia solution) 3 times. The DCM washes were pooled and concentrated under rotary 
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evaporation. The product was then precipitated in diethyl ether, filtered, and dried under 
vacuum. Yields were typically ~80%, and percent amination was 99% as verified by 1H 
NMR for the characteristic peak (3.1 ppm) of the PEG methylene protons adjacent to the 
amine end group. To synthesize PEG diacrylamide from PEG diamine, anhydrous DCM 
(75 mL) was added to PEG diamine (70 g, .0206 mol) and stirred until the solution 
became clear. The mixture was cooled to 4 ºC on ice. To this cooled solution was added 
diisopropylethylamine (DIPEA, 2 molar excess to PEG diamine, 5.7 mL, .0412 mol), 
followed by acryloyl chloride (4 molar excess to PEG diamine, 6.5 mL, 0.083 mol) 
dropwise with rapid stirring. The reaction proceeded overnight under argon protected 
from light and allowed to warm to room temperature. Aqueous reaction byproducts were 
removed by using aqueous 2M K2CO3 (2 molar excess to acryloyl chloride, 82.4 mL, 
0.164 mol) to phase separate the solution overnight. The lower organic phase was dried 
over MgSO4 to remove residual aqueous solution, filtered, precipitated in diethyl ether, 
and dried under vacuum to yield PEG diacrylamide. Yields were typically ~70%, and 
percent amidation was >90% as verified by 1H NMR for the characteristic peaks (5.6, 6.1, 
and 6.3 ppm) of the vinyl protons on the acrylamide end groups. 
4.2.4 Synthesis of MMP-sensitive acrylate-PEG-(peptide-PEG)m-acrylate conjugates 
The bis-cysteine peptide sequences CGPQGIWGQGCR (highly degradable, HD, 1261.42 
g/mol), CGPQGIAGQGCR (native collagen, NC, 1146.28 g/mol), and 
CGPQGPAGQGCR (least degradable, LD, 1130.23 g/mol) were custom synthesized by 
Aapptec (Louisville, KY). Each peptide was supplied as a trifluoroacetate salt at >95% 
purity. Peptides were evacuated of air and stored under argon (to minimize disulfide 
formation) at -80 ºC until needed. In a typical reaction, 183.8 µmol bis-cysteine peptide 
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(HD, 231.6 mg) was reacted with a 1.6 molar excess of PEGDA (MW 3400, 1 g, 294.1 
µmol) or PEGDAAm (MW 3400, 1 g, 294.1 µmol) by dissolution in 10 mL 100 mM 
sodium phosphate, pH 8.0 (94.7 mM Na2HPO4, 5.3 mM NaH2PO4). The reaction was 
sterile filtered through a 0.22 µm PVDF membrane (Millipore, Billerica, MA), protected 
from light and proceeded on a circular shaker for 85 hr at room temperature to yield 
acrylate-PEG-(peptide-PEG)m-acrylate or acrylamide-PEG-(peptide-PEG)m-acrylamide 
conjugates. The reaction mixture was dialyzed against 4 L 18 MΩ water (Millipore) with 
pre-swollen regenerated cellulose dialysis tubing (MWCO 3500, “snake-skin”, Pierce, 
Rockford, IL) for 24 hours (4 water changes). The dialyzed PEG-peptide conjugates were 
frozen overnight (-20 ºC), lyophilized, and stored at -80 ºC until use. 
4.2.5 Characterization of PEG-peptide macromers by GPC 
PEG-peptide conjugates were analyzed by GPC with a refractive index detector and DMF 
solvent using three tandem styrene-divinylbenzene (SDVB) columns spanning a linear 
MW range from 1 kDa to 500 kDa for polystyrene. PEG MW standards from 628 Da to 
478 kDa (Sigma) were used for assessment of the molecular weight of the PEG-peptide 
conjugates. 
4.2.6 PEG-peptide macromer photopolymerization to form hydrogels 
PEGDA, PEGDAAm, or PEG-peptide macromers were individually dissolved at 6-20% 
w/w concentration in PBS to make stock prepolymer solutions at the beginning of each 
experiment. The desired amounts of cell-adhesive and MMP-sensitive macromers were 
then mixed and diluted to the proper experimental concentration with PBS. To maintain 
concentration accuracy during dissolution, it was noted that PBS volume increased upon 
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addition of PEG-peptide conjugates by approximately 0.9 µL/mg added. All macromers 
are reported as their initial concentration during hydrogel polymerization. A solution (100 
mg/mL in 100% ethanol) of the photoinitiator Irgacure 2959 (I2959, Ciba, Tarrytown, 
NY) was added to a final working concentration of 0.05% w/v (by using 5 µL of the 
initiator solution per 1 mL hydrogel prepolymer solution). Solutions were thoroughly 
mixed and sonicated before polymerization. The prepolymer solution was transferred into 
plastic molds (96-well plate) for degradation assays, between glass plates for the 
modified Lowry assay, or dispensed onto a sterile slab of poly(dimethyl siloxane) 
(PDMS; Dow Corning) for explant encapsulation as described below. 
Photopolymerization was conducted with an Omnicure S2000 (320-500 nm, EXFO, 
Ontario, Canada) lamp at 100 mW/cm2 (measured for 365 nm) to yield solid hydrogels 
(exposure times reported in relevant sections below). Hydrogels containing explants were 
easily transferred into culture media with flat, round tip tweezers (EMS, Switzerland). 
4.2.7 Collagenase (MMP-1) degradation assay 
A collagenase degradation assay was employed to check the MMP-sensitivity of these 
hydrogels and their relative degradation behavior, in a similar fashion as described 
previously (Mann et al., 2001a). Briefly, hydrogel prepolymer solutions were made in 
HEPES-buffered saline (HBS; 10 mM, pH 7.4) containing 0.2 mg/mL sodium azide (to 
inhibit microbial growth), mixed with initiator, and polymerized for 60 seconds as 
described above. Hydrogels (150 µL starting volume per gel) were swollen for 36 hr at 
37 ºC and weighed to assess equilibrium swollen weight. These swollen hydrogels were 
then transferred to a 0.2 mg/mL collagenase 1 (MMP-1) solution (made with the same 
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buffer), and their wet weight was monitored over time (3 gels per condition). Control 
hydrogels were incubated in buffer without enzyme. 
4.2.8 Synthesis and characterization of cell-adhesive acrylate-PEG-peptide conjugates 
Cell adhesive or non-adhesive acrylate-PEG-peptide conjugates were prepared in a 
similar manner to the MMP-sensitive conjugates by using a 1.0 molar equivalent of 
PEGDA (MW 3400) for the monocysteine peptides CGRGDS (adhesive, 593.59 g/mol) 
and CGRGES (non-adhesive, 607.62 g/mol). These conjugates were characterized by 
GPC as described above. 
4.2.9 Characterization of the immobilization stability of cell-adhesive acrylate-PEG-
peptide conjugates 
To verify the immobilization stability of acrylate-PEG-RGDS in PEG gels we developed 
a modified Lowry Assay (Sigma) in prepolymer solutions or in solid hydrogels to 
quantify peptide concentration in situ. For solutions, acrylate-PEG-CGRGDS solutions 
were made in sterile water (the Lowry assay is not reliable in PBS) and assessed as 
described below with the free peptide CGREDV used as a standard. For solid hydrogels, 
10% w/w PEGDA 6000 hydrogel prepolymer solutions were made containing 0, 0.25, 2, 
or 4 µmol/mL acrylate-PEG-CGRGDS. Initiator was added as described above, then each 
solution was transferred to a glass chamber composed of thin rubber spacers sandwiched 
between two glass slides (chamber dimensions: 30 mm x 40 mm x 0.48 mm thick). 
Hydrogels were polymerized for 120 seconds (25 mW/cm2) and then sliced into 3 
sections to yield hydrogels approximately 7 mm x 15 mm x 0.48 mm. Gels were 
subjected to a modified Lowry assay immediately after polymerization, or after a 24 hour 
or 72 hour incubation at 37 ºC in sterile water (changed daily). At these specified times, 
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hydrogels were blotted dry with laboratory wipes, then placed in a test tube with 1 mL 
deionized water. While vigorously mixing, 1 mL Lowry reagent was added according to 
the vendor's recommendations. Mixing continued for 40 seconds and hydrogels were left 
at room temperature for 20 minutes. While vigorously mixing, 0.5 mL Folin-Ciocalteu's 
phenol reagent was added. Mixing continued for 40 seconds and hydrogels were left at 
room temperature for 30 minutes. Hydrogels were blotted dry, transferred to plastic 
cuvettes and assessed with a UV/Vis spectrophotometer (750 nm) transverse to the wide 
hydrogel face. Absorbance values were normalized to PEGDA gels without peptide. 
4.2.10 Characterization of cell attachment to adhesive acrylate-PEG-peptide conjugates 
Cell-adhesive 20% w/w PEGDA 3400 hydrogels were formed containing 4 µmol/mL 
acrylate-PEG-CGRGDS or acrylate-PEG-CGRGES in PBS and swollen for 24 hours at 
37 ºC. Hydrogels were briefly rinsed with media, then seeded with HUVECs (15,000 
cells/cm2). Hydrogels were rinsed with PBS after 24 hours and photographed to check 
cellular attachment. 
4.2.11 Mechanical testing 
The shear modulus of PEG gels was obtained using an AR 2000 oscillating rheometer 
(TA Instruments) with a 20 mm stainless steel parallel plate.  For measurements taken 
during gel polymerization, the head was lowered onto 140 µL of unpolymerized gel 
solution to a gap of 448 µm such that gel filled the entire cylindrical volume between the 
plates.  Measurements were taken at a frequency of 1 Hz and strain of 1% during 
photopolymerization using an Omnicure S2000 (320-500 nm, EXFO, Ontario, Canada) 
lamp at 100 mW/cm2 (measured for 365 nm), with values reported at 30 seconds of UV 
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exposure.  Measurements of pre-swollen gels were taken on a temperature-controlled 
Peltier plate at 37ºC.  Cylindrical gel samples were created from 125 μL of precursor 
solution, covalently linked to 3-(trimethoxysilyl)propyl methacrylate (Sigma)-treated 
glass microscope slides and then swollen in PBS for 36 hours.  Immediately prior to 
testing, the slides were removed from media and carefully blotted dry with laboratory 
wipes.  The heights and diameter of the swollen gels were measured with calipers and 
were typically ~1 mm thick and ~19 mm in diameter.  The head was lowered to a gap 
corresponding to 10-20% axial compression of the samples.  Measurements were taken at 
a frequency of 1 Hz and strain of 1%. 
4.2.12 Chick aortic arch explant angiogenesis assay 
Chick aortas were isolated from 12-day-old chick embryos (Charles River Labs, Preston, 
CT). Aortic arches were cleaned of excess fibroadipose tissue, sectioned into ~0.5 mm 
sized rings, and submerged inside a 30 µL droplet of hydrogel prepolymer solution. 
Polymerization was performed for 30 seconds as described above, and culture media 
(EGM-2; 0.75 mL per hydrogel) was changed on day 1 and every 3 days thereafter. 
Hydrogels were photographed daily with oblique lighting phase contrast microscopy to 
optically exclude 2D cell migration on the surface of hydrogels and instead visualize only 
those cells which migrated in 3D within the hydrogels. Sprout area was assessed by 
image thresholding and edge-finding filters (Matlab), 2 sides per ring, 4-6 rings per 
experimental group.  Statistics were assessed by one-way ANOVA with Tukey’s HSD 
post-hoc testing, and p-values less than 0.05 were considered significant. For endothelial 
cell labeling experiments, aortic arch explants were incubated with rhodamine-lectin 
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(Lens culinaris agglutinin, 20 μg/ml, Vector Laboratories) for 1.5 hours before 
encapsulation in hydrogels. 
 
4.3 Results 
4.3.1 Material design and analysis 
 To develop a PEG hydrogel system in which degradable and adhesive 
components are incorporated using simple chemistries, we first employed the step-growth 
polymerization of PEGDA or PEGDAAm with MMP-sensitive peptides.  The resulting 
high molecular weight photoactive macromers could then be crosslinked along with cell-
adhesive PEG conjugates into hydrogels by photopolymerization (Fig. 4.1A, 4.2A).  We 
started with the synthesis of PEGDA or PEGDAAm (Fig. 4.1A,B), as previously 
described (Gobin and West, 2002; Mann et al., 2001a; West and Hubbell, 1999).  While 
initial studies used PEGDA given its easy synthesis and rapid reaction with thiol-bearing 
peptides, PEGDAAm was ultimately preferred for long-term tissue explant studies given 
the stability of the amide bond in PEGDAAm compared to the hydrolytically unstable 
ester bond in PEGDA.   
 MMP-sensitive peptides were flanked with leading and lagging cysteine residues 
to react with terminal acrylates and acrylamides on PEGDA and PEGDAAm via 
Michael-type addition.  Since PEG is linear, step-growth polymerization of bis-cysteine 
peptides with PEGDA or PEGDAAm did not result in hydrogel formation directly but led 
to macromer chain extension such that multiple MMP-sensitive peptides were 
incorporated into each polymer chain.  These extended chains could then be crosslinked 
into hydrogels by photopolymerization using unreacted terminal acrylate and acrylamide 
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groups.  MMP-sensitive peptide sequences were selected to cover a range of 
degradabilities based on previous studies (Imper and Van Wart, 1998; Lee et al., 2005; 
Lutolf et al., 2003a):  highly degradable (“HD”), collagen native (“CN”), and least 
degradable (“LD”) (Fig. 4.1A).   
 Step-growth polymerization is strongly controlled by the stoichiometric ratio of 
the reactants.  In order to ensure that acrylates remained at the terminal ends of MMP-
sensitive macromers (to enable later photopolymerization), an excess of PEGDA or 
PEGDAAm compared to peptide was used.  With a PEGDA:peptide molar ratio of 1.6, 
more than 90% of the PEGDA reacted with peptide (sum of “high” and “medium” 
molecular weights in Fig. 4.2B), indicating successful Michael-type addition.  
Surprisingly, approximately 60% of the resultant molecular species were greater than 500 
kDa.  Unreacted MMP-sensitive peptide was not observed by GPC, either due to the 
completeness of the reaction or from being washed away during dialysis.  Importantly, all 
three MMP-sensitive peptides showed nearly identical polydispersity, indicating that 
Michael-type addition proceeded similarly for each peptide sequence. Reacted species are 
of the form acrylate-PEG-(peptide-PEG)m-acrylate, and for a macromer molecular weight 
of 500 kDa, the m-value is approximately 100.  PEGDAAm reacted with peptide at a 
molar ratio of 1.6 demonstrated a similar profile, with 85% of the PEGDAAm reacted 
with peptide and approximately 45% greater than 500 kDa (data not shown).  Here, 
reacted species are of the form acrylamide-PEG-(peptide-PEG)m-acrylamide. 
 To make pendant cell-adhesive RGDS peptide, we reacted CGRGDS peptide with 
PEGDA at a PEG:peptide ratio of 1.0.  GPC analysis showed that 87% of the PEGDA 
reacted with peptide. The lack of a second cysteine residue on this peptide prevents step-
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growth polymerization and thus the possibility of high molecular weight macromers.  
However, double conjugation in the form peptide-PEG-peptide is possible in this 
reaction. Of the peptide-conjugated PEGDA, 63% was in the preferred acrylate-PEG-
CGRGDS form. These data suggested sufficient coupling of peptide for their covalent 
incorporation into hydrogels as cell-adhesive pendant chains.   
This design strategy builds on components from previously described PEG 
systems:  Michael-type addition to couple thiol-bearing peptides to acrylate and 
acrylamide groups on PEG as employed by Hubbell and colleagues (Elbert and Hubbell, 
2001; Lutolf et al., 2003a; Lutolf et al., 2003b) and photopolymerization of acrylated 
PEG derivatives into hydrogels similar to West and colleagues (Gobin and West, 2002; 
Mann et al., 2001a; West and Hubbell, 1999).  This strategy is attractive because it 
employs simple chemistries and starting reagents—avoiding costly and limited reagents 
such as heterobifunctional or multi-arm PEGs—while preserving the ability to 
photopolymerize and spatially pattern hydrogels.   
 Figure 4.1.  Synthesis of PEGDA, PEGDAAm, and cell-adhesive and MMP-sensitive 
conjugates.  (A) Scheme for synthesizing cell-adhesive or MMP-sensitive PEG 
conjugates from PEGDA.  PEG is reacted with acryloyl chloride to form PEGDA, which 
is then reacted with cysteine-bearing peptides via Michael-type addition to form cell-
adhesive or, in a separate reaction, MMP-sensitive PEG–acrylate macromers.  (B) 
Synthesis of PEGDAAm, which is also used to form cell-adhesive and MMP-sensitive 
conjugates as in (A), but with more stable amide bonds replacing ester bonds.  PEG is 
reacted with methanesulfonyl chloride to form PEG dimesylate, which is reacted with 
aqueous ammonia to form PEG diamine.  PEG diamine is reacted with acryloyl chloride 
to form PEGDAAm. 
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 Figure 4.2.  Hydrogel structure schematic and GPC analysis of MMP-sensitive 
macromers.  (A) Schematic illustration of hydrogel structure. Photopolymerization of 
the photoactive precursors from Fig. 4.1 yields bioactive hydrogels with multiple MMP-
sensitive peptides per backbone chain and pendant cell-adhesive ligands tethered from 
sites of acrylate crosslinking.  (B) GPC analysis of MMP-sensitive PEG-diacrylates 
plotted against PEG MW standards.  Reaction of MMP-sensitive peptides with a 1.6 
molar excess of PEGDA via step-growth polymerization resulted in more than 90% 
conjugation (sum of medium and high MWs), with a majority of the molecular weight 
species greater than 500 kDa. Highly degradable (‘‘HD’’), collagen native (‘‘CN’’), and 
least degradable (‘‘LD’’) PEG–peptide conjugates show nearly identical polydispersity. 
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4.3.2 Degradable peptide sequences regulate angiogenic sprouting 
 We first tested whether incorporation of specific MMP-sensitive peptide 
sequences rendering hydrogels more or less degradable could regulate angiogenic 
sprouting in these gels, as angiogenesis is known to be regulated by the interplay of cell-
secreted MMPs with the extracellular matrix (Chun et al., 2004; Ghajar et al., 2008b).  
Sequences were chosen to be derived from the native collagen sequence (CN) or 
substantially more (HD) or less (LD) degradable by MMPs.  Relative to the CN peptide, 
the HD peptide is 840%, 310%, and 240% more degradable by MMP-1, MMP-2, and 
MMP-9, respectively (Imper and Van Wart, 1998).  In contrast, the LD peptide is 0.5%, 
5%, and 5% less degradable by those MMPs.  To characterize degradation profiles of the 
hydrogels, hydrogels were allowed to reach equilibrium swelling in aqueous buffer and 
then degraded in collagenase 1 (MMP-1) solution while their wet weight was monitored.  
Hydrogels swelled dramatically in aqueous buffer (Fig. 4.3A), a result of the long chain 
lengths of the macromer precursors.  This substantial swelling, along with the presence of 
multiple MMP-sensitive peptides within each macromer chain, likely contributed to the 
rapid degradation of the gels as compared to other similar MMP-sensitive hydrogels 
(Gobin and West, 2002; Mann et al., 2001a; West and Hubbell, 1999).  The observed 
degradation profiles differed substantially from the reported degradabilities of the 
peptides in soluble form:  hydrogels containing HD and CN peptides had very similar 
profiles, while LD hydrogels required only twice the amount of time to degrade fully 
(Fig. 4.3B).  These discrepancies can be attributed at least in part to the presence of 
multiple degradable peptides along each macromer chain such that cleavage of only one 
peptide cleaves the entire chain, as well as to the concentration of collagenase used 
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(selected to be consistent with the literature but perhaps too high to be sensitive to 
sequence differences).   
 To study angiogenic sprouting in hydrogels of varying degradabilities, we used 
the chick aortic arch assay described in Chapter 2.  The three MMP-degradable sequences 
were incorporated in hydrogels to vary only MMP susceptibility, while holding polymer 
weight percent and adhesive peptide concentration constant.  Significantly more 
angiogenic sprouting was observed in HD hydrogels over 4 days, with CN hydrogels 
exhibiting intermediate sprouting and LD hydrogels minimal sprouting, as measured by 
area of sprouting from explants (Fig. 4.4A,B). Moreover, angiogenic sprouting was 
completely suppressed to undetectable levels by substitution of CGRGDS with the non-
adhesive CGRGES peptide, confirming that the hydrogels support angiogenic invasion 
only in the presence of an adhesive peptide. We verified that endothelial cells were a 
principal component of the observed explant sprouts by labeling the chick arches with an 
endothelial-specific lectin (Fig. 4.4C).  These results demonstrate the importance of 
MMP susceptibility in regulating sprouting angiogenesis, as well as our ability to control 
the angiogenic response by incorporation of specific bioactive peptide sequences in PEG 
hydrogels.  
 Figure 4.3.  Characterization of hydrogel swelling and degradation in collagenase.  
(A) MMP-sensitive hydrogels (made from HD, CN, or LD peptides) were polymerized at 
10% w/w and then swollen to equilibrium over 36 hrs. Graph shows average of three 
samples, ± standard deviation.   (B) Swollen hydrogels were degraded in 0.2 mg/mL 
collagenase (n = 3) or incubated in buffer (n = 1) up to 8 hrs while their wet weight was 
monitored.  Note that HD and CN have overlapping degradation curves.  Bars indicate 
standard deviation. 
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Figure 4.4.  MMP sensitivity of hydrogels regulates ex vivo sprouting.  (A) 
Representative images of chick aortic ring explants sprouting into hydrogels over time.  
In 8-wt% gels with 1.0 μmol/mL CGRGDS density, angiogenic sprouting varies with the 
MMP-susceptibility of the hydrogel backbone.  No detectable sprouting occurred in 
negative control hydrogels containing RGES instead of RGDS peptide.  Scale bar for all 
images = 250 μm.  (B) Quantification of sprout area at day 4, n = 6 per condition.  Graph 
shows means with standard deviation, all comparisons are significant, p < 0.003 by one-
way ANOVA and Tukey’s HSD post-hoc test. (C) Fluorescent staining with rhodamine-
labeled lectin implicates endothelial cells as a principal component of the angiogenic 
sprouts in these hydrogels.  Scale bar = 100 μm. 
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4.3.3 Interaction between adhesive ligand density and mechanical compliance in 
regulating angiogenic sprouting 
While the roles of cell-ECM adhesion and ECM compliance in angiogenesis have 
independently been studied with tremendous interest (reviewed in Chapter 1), the 
interplay between the two has not yet been investigated, primarily because of the 
difficulty of segregating their effects in traditional 3D material systems.  Varying 
collagen, fibrin, or Matrigel density varies not only adhesive ligand density but also ECM 
stiffness (Duong et al., 2009; Paszek et al., 2005; Zaman et al., 2006), although studies 
have employed chemical crosslinking of these native ECMs to increase matrix stiffness 
while keeping ligand density constant (Kuzuya et al., 1998; Standeven et al., 2007) or 
added exogenous adhesive ligand to vary ligand density while keeping stiffness constant 
(Zaman et al., 2006).  In this latter study, tumor cell migration in 3D Matrigel matrices 
was found to be regulated by a complex interaction between ligand density, stiffness, and 
MMP proteolytic activity.  A biphasic response to changes in integrin-adhesive ligand 
binding was observed, similar to previous studies on 2D surfaces (Palecek et al., 1997; 
Wu et al., 1994).  A biphasic response to changes in compliance was also observed, and 
the authors suggested a shift in optimal adhesive ligand density with changes in 
compliance (i.e. lower density with increased compliance) such that contractile force and 
adhesiveness were in balance, as predicted by a model (Zaman et al., 2005).  Using 
artificial 3D matrices, independent variation of adhesive ligand density has demonstrated 
a biphasic effect of ligand density on migration of several cell types, including fibroblasts 
and smooth muscle cells (Burgess et al., 2000; Gobin and West, 2002; Lutolf et al., 
2003a; Schense and Hubbell, 2000).  Using a 2D polyacrylamide gel system in which 
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ligand density and stiffness could be varied independently, the two properties were found 
to be coupled in regulating smooth muscle cell spreading:  while these cells generally 
exhibit a biphasic spreading response to ligand density, cells on softer gels were 
relatively insensitive to increasing collagen ligand density and remained round, whereas 
cells on stiffer gels demonstrated a robust biphasic increase in spreading in response to 
increased ligand density (Engler et al., 2004).    
Here, we have begun to study the coordinate regulation of angiogenic sprouting 
by adhesive ligand density and matrix stiffness using our PEG hydrogels that allow for 
independent variation of these properties.  We first verified our ability to immobilize 
different amounts of the adhesive RGDS ligand in the hydrogels.  To quantify the amount 
of RGDS entrapped or immobilized in the hydrogel during polymerization and its 
subsequent stability in the hydrogel over time, we developed a modified Lowry Assay for 
in situ quantification (Lowry et al., 1951).  We confirmed that the assay, which provides 
a colorimetric measurement of the total amount of peptide bonds present and is typically 
used for large proteins, could be applied to quantify the concentration of short peptides 
using the CGREDV peptide as a standard (Fig. 4.5A).  When applied to our acrylate-
PEG-CGRGDS materials diluted in solution, measured peptide concentrations fell within 
40-50% of expected values (Fig. 4.5B).  We then applied this assay to characterize the 
immobilization of CGRGDS in solid hydrogels (Fig. 4.5C).  We followed relative peptide 
retention in hydrogels over time and observed that hydrogels lost between 30-50% of the 
PEGDA-peptide conjugate in the first day of equilibrium swelling, with the remaining 
immobilized peptide stable in the gel for several days (Fig. 4.5D).  The initial loss of 
peptide represented double-conjugated peptide-PEG-peptide from the reaction of PEGDA 
96 
 
with CGRGDS peptide, which was physically entrapped in the gel at first but diffused 
away during equilibrium swelling.  These results are consistent with GPC analysis 
indicating 63% of CGRGDS conjugate in the preferred acrylate-PEG-CGRGDS form.  
To confirm the bioactive potency of the cell-adhesive conjugate, we measured adhesion 
of HUVECs to PEGDA hydrogels containing the cell-adhesive CGRGDS or non-
adhesive CGRGES peptide (Fig. 4.5E).  While CGRGES peptide was unable to support 
HUVEC adhesion, CGRGDS peptide supported robust HUVEC adhesion and cell 
spreading.  This assay confirmed that sufficient adhesive peptide is immobilized in the 
hydrogels to support cell adhesion.  In subsequent studies, we varied the concentration of 
RGDS peptide in hydrogels to investigate effects on angiogenic sprouting in 3D. 
To vary stiffness of the gels, we altered crosslinking density by controlling 
polymer weight percent.  The shear modulus of both non-swollen PEGDA gels (Fig. 
4.6A) and swollen PEGDAAm gels (Fig. 4.6B) increased with increasing weight percent, 
with the storage modulus of 4-6 weight percent degradable, swollen PEGDAAm gels 
ranging from 100 to 1300 Pa.  We did note an increase in modulus with increasing 
concentrations of CGRGDS-conjugated PEG (Fig. 4.6A), as predicted by a recent study 
(Beamish et al.).  This prompted us to incorporate non-adhesive CGRGES peptide along 
with CGRGDS in the gels such that the total concentration of monoacrylated, ligand-
conjugated PEG remained constant for all conditions.  Gels containing both CGRGDS 
and CGRGES at different ratios but the same total peptide concentration had similar 
mechanical properties (Fig. 4.6B), confirming our ability to modulate adhesion and 
mechanical compliance independently in these gels. 
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Figure 4.5.  Characterization of the immobilization efficiency and stability of 
acrylate–PEG–peptide macromers in PEGDA gels.  (A) The Lowry assay, typically 
only used for large proteins, produced a linear standard curve from the short, soluble 
CGREDV peptide, even at low concentrations.  (B) This standard curve was used to 
quantify the solution-based concentration of acrylate–PEG–CGRGDS and acrylate–
PEG–CGRGES conjugates, with a deviation from expected of 40–50%, with values 
comparable between both peptides. Bars indicate standard error.  (C) Gross appearance of 
hydrogel slabs after modified Lowry assay in situ showing characteristic blue color with 
starting peptide concentration (μmol/mL). The linear dependence on concentration was 
also valid in solid hydrogels (bars indicate standard deviation).  (D) The assay tracked 
CGRGDS retention over time within hydrogels.  A large percent of RGDS was lost on 
the first day during hydrogel equilibrium swelling.  The remaining peptide was stable for 
at least 2 more days in the gel (n=3 for all samples), with up to 75% retention.  Bars 
indicate standard deviation.  (E) HUVEC morphology on PEGDA hydrogels with 4.0 
μmol/mL PEG-CGRGES (left) or PEG–CGRGDS (right) 24 hours post-seeding. Scale 
bars = 25 μm. 
 Figure 4.6.  Rheometry of PEG hydrogels with varying weight percent and RGDS 
density.  (A) The storage modulus (G’) of 6 and 8 wt-% non-degradable PEGDA gels 
containing varying concentrations of RGDS ligand (0-20 μmol/mL), as measured during 
photopolymerization.  (B) The storage modulus of 4-6 wt-% degradable PEGDAAm gels 
containing varying concentrations of RGDS ligand (0-10 μmol/mL) with constant total 
ligand density (10 μmol/mL) using non-adhesive RGES ligand.  Gels were measured 
after 36 hours of equilibrium swelling in buffer.   
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We have begun to characterize sprouting from chick aortic rings into PEG gels of 
varying adhesive RGDS concentrations and polymer weight percents to study the 
interaction between the two in regulating angiogenesis.  In preliminary studies, 3-6 
weight percent PEGDAAm gels containing 0, 0.1, 1, and 10 μmol/ml RGDS (total 
concentration of RGDS + RGES is 10 μmol/ml for all conditions) were used.  All gels 
contained the HD degradable peptide sequence.  At 3 days after aortic ring encapsulation, 
a biphasic response to changes in weight percent was observed, with the greatest amount 
of sprouting in 4 weight percent gels (Fig. 4.7-4.11).  Interestingly, while sprouting in 3 
and 4 weight percent gels exhibited a biphasic response to increased RGDS ligand 
density, sprouting in 5 and 6 weight percent gels was relatively insensitive to changes in 
ligand density and perhaps even greater with increased ligand density.  Minimal 
sprouting was observed in gels containing RGES only.  Degradation over time appeared 
to alter the properties of the gels, with 3 weight percent gels degraded by 4 days and 
sprouting similarly high in 4-6 weight percent gels at day 6.  Unexpectedly, we noticed 
increased degradation of gels containing lower concentrations of RGDS peptide such that 
sprouts in gels containing 0.1 and 1 μmol/ml RGDS began to regress at 4-5 days, while 
sprouts in gels containing 10 μmol/ml RGDS continued to grow past 6 days (Fig. 4.11C).  
These data, while preliminary, suggest a coupling between adhesive ligand density and 
stiffness in regulating angiogenic sprouting.  While there was a biphasic response in 
sprouting to changes in stiffness at most ligand densities, a biphasic response to changes 
in ligand density was observed only in softer gels, with higher ligand densities appearing 
to support maximal sprouting in stiffer gels.  These results are consistent with our gene 
expression data (Figs. 2.5 and 2.7) and previous reports of enhanced angiogenesis at 
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intermediate stiffness (Mammoto et al., 2009), as well as with the model of 3D tumor 
migration described above (Zaman et al., 2005).  A wider range of ligand densities and 
stiffnesses will be investigated to study the effects of a full set of physiologically relevant 
conditions on angiogenic sprouting, and these same materials will be implanted 
subcutaneously in mice to verify these findings in vivo. 
 
 
 
Figure 4.7.  Ex vivo sprouting in degradable PEGDAAm gels is controlled by 
stiffness and adhesive ligand density, day 2.  Representative images of chick aortic ring 
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-% 
and RGDS density (with sum of RGDS and non-adhesive RGES constant).  Scale bar for 
all images = 250 μm.   
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 Figure 4.8.  Ex vivo sprouting in degradable PEGDAAm gels is controlled by 
stiffness and adhesive ligand density, day 3.  Representative images of chick aortic ring 
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-% 
and RGDS density (with sum of RGDS and non-adhesive RGES constant).  Scale bar for 
all images = 250 μm.   
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Figure 4.9.  Ex vivo sprouting in degradable PEGDAAm gels is controlled by 
stiffness and adhesive ligand density, day 4.  Representative images of chick aortic ring 
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-% 
and RGDS density (with sum of RGDS and non-adhesive RGES constant).  Note 3 wt-% 
gels have degraded by this time.  Scale bar for all images = 250 μm.   
104 
 
 
 
 
Figure 4.10.  Ex vivo sprouting in degradable PEGDAAm gels is controlled by 
stiffness and adhesive ligand density, day 6.  Representative images of chick aortic ring 
explants sprouting into degradable (HD peptide) PEGDAAm hydrogels of varying wt-% 
and RGDS density (with sum of RGDS and non-adhesive RGES constant).  Note 3 wt-% 
gels have degraded by this time.  Scale bar for all images = 250 μm.   
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Figure 4.11.  Quantification of ex vivo sprouting in degradable PEGDAAm of 
varying stiffness and adhesive ligand density.  (A) Quantification of chick aortic ring 
sprouting into degradable (HD peptide) PEGDAAm hydrogels as a function of hydrogel 
weight percent and RGDS ligand density at days 3 and 6 after encapsulation.  (B) 
Contour and surface plots showing sprouting as a function of weight percent and RGDS 
density at day 3 (interpolation of data).  (C) Sprouting in 4 wt-% gels as a function of 
RGDS density over 6 days.  
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4.4 Discussion 
 
Here we describe an inexpensive, flexible, and readily available route to bioactive 
PEG-based hydrogels, which can modulate ex vivo angiogenic sprouting through 
chemical control of MMP susceptibility, adhesive ligand density, and mechanical 
stiffness. Step-growth polymerization via Michael-type addition was employed to create 
high molecular weight bioactive macromers of the form acrylate-PEG-(peptide-PEG)m-
acrylate.  These macromers, when photopolymerized along with pendant adhesive ligands 
via terminal acrylate groups, resulted in highly hydrated, degradable gels suitable for cell 
and tissue encapsulation.  3D angiogenic sprouting from chick aortic rings was controlled 
by the MMP susceptibility of the hydrogel backbone, the concentration of adhesive 
RGDS peptide, and the mechanical stiffness of the hydrogel.  This control allows us not 
only to find optimal conditions for sprouting at a given time but also to tune parameters 
based on desired time for vascularization and material properties required for other cell 
types in a potential engineered tissue construct.  The ability to isolate parameters in this 
material system also provides an invaluable tool for mechanistic studies of ECM 
regulation of angiogenesis. 
Work is ongoing to expand the range and combinations of adhesive ligand 
density, stiffness, and MMP sensitivity so that we can map angiogenic responses to these 
parameters in physiologically relevant ranges.  Several of these combinations will be 
tested in subcutaneous implants in mice to validate results in vivo.  We will also explore 
biological mechanisms behind observed responses, including the contribution of 
proliferation to sprouting responses and whether differential MMP activity is responsible 
for differences in degradation rate in gels of varying RGD density.  These studies will 
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ultimately provide further insight into ECM regulation of angiogenesis and aid in the 
rational design of materials for tissue repair.   
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
5.1 Conclusions 
 
 The work in this thesis has aimed to further our understanding of the regulation of 
angiogenesis by cellular interactions with the ECM, and in particular the role of cell-
ECM adhesion.  Previous studies had established a requirement for integrin-mediated 
adhesion in angiogenesis (Avraamides et al., 2008; Brooks et al., 1994a; Friedlander et 
al., 1995; Kim et al., 2000; Tanjore et al., 2008; Yang et al., 1993), but recent work has 
also shown that limiting integrin-mediated adhesion through integrin antagonists can 
actually enhance angiogenesis (Reynolds et al., 2009).  Another avenue of inquiry 
demonstrated that gradual increases in endothelial cell spreading could regulate a switch 
from apoptosis to tubulogenesis to proliferation (Chen et al., 1997; Dike et al., 1999; 
Ingber, 1990; Ingber and Folkman, 1989).  However, these observations still lacked a 
mechanistic basis and a connection to physiological sprouting.  Through a combination of 
microfabrication tools and native and engineered materials to control the interaction of 
endothelial cells with the ECM, our work here has confirmed that quantitative changes in 
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adhesion can regulate both the extent and character of angiogenesis.  We show that 
limited adhesion drives sprouting in part by stimulating an activated endothelial 
phenotype associated with vascular invasion and remodeling, which can now be 
characterized by a specific gene expression profile.  We also implicate Pyk2 in regulating 
both limited adhesion-induced gene expression and angiogenic sprouting.  Another 
existing challenge in the field is understanding how different components of the ECM 
regulate angiogenesis.  While adhesive ligand density, ECM stiffness, porosity, and 
degradability are difficult to separate in native ECMs, our synthetic PEG materials have 
allowed us to begin to study in a systematic fashion the effects of various ECM properties 
on angiogenesis.  These hydrogels also support robust vascularization, which has not 
been achieved in many synthetic materials, and thus have great potential in tissue 
engineering applications. 
In Chapter 2, we observed an increase in angiogenic sprouting with decreasing 
densities of the native ECM fibrin and used gene expression profiling to probe the 
contributions of various ECM properties to this response.  We noted an upregulation of 
genes associated with an activated angiogenic response—including matrix invasion, 
growth factor signaling, and cell-cell and cell-ECM adhesion—in endothelial cells 
cultured on small micropatterned islands of fibronectin as compared to fully spread cells.  
A similar response was observed in cells cultured on low versus high densities of 
fibronectin, implicating limited cell-ECM adhesion as an important driver of angiogenic 
gene expression.  In investigating the roles of other microenvironmental properties that 
could regulate angiogenic sprouting, we observed increased angiogenic gene expression 
in cells cultured on soft versus stiff substrates, as well as in cells with reduced cell-cell 
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contact.  Altogether, these results suggest a role for limited cell-ECM adhesion and 
mechanics in promoting angiogenesis, as well as a complex interplay between cell-ECM 
and cell-cell interactions that could explain differences in behavior along a single 
angiogenic sprout or within different tissue contexts. 
 In Chapter 3, we investigated a mechanistic basis for the increased angiogenesis 
observed with limited cell-ECM adhesion.  We screened inhibitors of several molecules 
that are known to transduce adhesion signaling, including ERK, ROCK, Src family 
kinases, FAK, and the FAK relative Pyk2.  While ERK and ROCK inhibition had 
minimal effect on angiogenic gene expression, Src family kinase, FAK, and Pyk2 
inhibition decreased gene expression.  We focused on FAK and Pyk2 and found, through 
more specific molecular manipulations, that Pyk2, but not FAK, is responsible for 
increased gene expression in less adherent cells.  Pyk2 inhibition also decreased 
sprouting from endothelial spheroids and aortic arch explants, confirming its importance 
in functional angiogenesis assays.  Further downstream, we looked for potential 
transcriptional regulators of the gene expression profiles observed through CARRIE 
analysis and identified several transcription factors that could be responsible for gene 
expression changes resulting from alterations in cell-ECM adhesion. 
 In Chapter 4, we developed an adhesive, degradable PEG-based hydrogel that 
supports 3D angiogenic sprouting from aortic arch explants.  These wholly synthetic 
materials allow for more precise control over ECM properties such as compliance, 
adhesive ligand density and type, and degradability.  We first demonstrated that specific 
MMP-sensitive peptides rendering the hydrogels more or less degradable could control 
the degree of angiogenic sprouting.  We then examined the interplay between adhesive 
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ligand density and mechanical stiffness in regulating angiogenesis.  Through these 
multiple tunable parameters, this material can not only be used for vascularizing 
engineered implants but also as a platform to study how ECM properties regulate 
angiogenesis independent of others. 
 
5.2 Future Directions 
5.2.1 Understanding the physiological importance of the adhesive and mechanical 
regulation of angiogenesis 
 Our studies and previous reports (Chen et al., 1997; Dike et al., 1999; Ingber and 
Folkman, 1989) suggest that the degree of cell-ECM adhesion and ECM mechanics can 
regulate not only the overall amount of sprouting but also a switch between distinct 
endothelial cell behaviors important for angiogenesis, such as proliferation versus 
invasion and capillary morphogenesis.  In what physiological contexts might these 
observations be relevant?  It is possible that changes in cell-ECM interaction along a 
single angiogenic sprout could be responsible for the diverse behaviors observed.  
Enhanced MMP production and ECM degradation at the sprouting tips (Yana et al., 
2007) could decrease adhesion and thereby promote migration and cellular invasion, and 
increased ECM deposition along the stalks could be responsible for the observed 
proliferation in these regions (Gerhardt et al., 2003).  Notably, our microarray analysis 
identified upregulation of genes associated with tip cells—VEGFR-2/KDR, PDGF-B, 
and MT1-MMP/MMP14 (Gerhardt et al., 2003; Yana et al., 2007)—in cells with limited 
adhesion exposed to VEGF, suggesting that adhesive gradients may indeed play an 
important role in dictating cellular behavior along angiogenic sprouts.  To investigate this 
possibility, it would be interesting to localize regions of high ECM degradation and 
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deposition along angiogenic sprouts via high-resolution imaging and see if these spatial 
patterns correlate with those of endothelial functions.  While proliferation has already 
been shown to be higher in stalks (Gerhardt et al., 2003), we have not yet explored 
whether the genes we identified as associated with an activated angiogenic phenotype are 
differentially expressed along angiogenic sprouts.  In situ labeling (similar to (Raj et al., 
2008) to determine spatial expression patterns would be instrumental to understanding 
how diverse behaviors might be coordinated along sprouts, as well as identify potential 
markers that could be used to visualize endothelial phenotypes besides proliferation.  
Additionally, our lab has recently developed a method to measure cellular forces in 3D 
(Legant et al., submitted).  Using this tool, we can potentially measure forces exerted by 
cells along an angiogenic sprout and see if these forces correlate with proliferation or 
gene expression patterns. 
5.2.2 Further understanding the mechanism behind adhesion regulation of 
angiogenesis 
 While our studies revealed a role for Pyk2 in regulating angiogenesis promoted by 
limited adhesion, several questions still remain.  Does Pyk2 have a similar role in vivo?  
While Pyk2-knockout mice are viable (Okigaki et al., 2003), previous studies 
demonstrated impaired revascularization of ischemic hindlimbs in Pyk2-knockout adult 
mice (Matsui et al., 2007), consistent with the limited expression of Pyk2 in embryonic 
endothelium (Avraham et al., 1995; Sasaki et al., 1995).  We are planning to investigate 
the ability of Pyk2-knockout endothelial cells to vascularize less versus highly adhesive 
materials using subcutaneous implants and the ex vivo aortic ring sprouting assay.  Given 
our hypothesis that Pyk2 regulates angiogenesis in limited adhesive contexts while FAK 
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regulates angiogenesis in highly adhesive contexts, it would be interesting to carry out the 
same experiments with FAK-knockout mice.   
 Our results also suggested that Pyk2 and FAK might be responsible for regulating 
different cell types in angiogenic sprouts.  While inhibition of Pyk2, but not FAK, 
decreased sprouting from spheroids of pure endothelial cells, they appeared to regulate 
sprouting synergistically from aortic arch explants containing both endothelial cells and 
supporting mesenchymal cells.  This result raised the possibility that Pyk2 is acting 
primarily in endothelial cells, while FAK is regulating the behavior of mesenchymal 
cells.  It would be interesting to look at Pyk2 and FAK activity in the two cell populations 
in sprouts, as well as to manipulate Pyk2 in endothelial cells and FAK in mesenchymal 
cells before mixing together into spheroids to observe sprouting. 
 Upstream of Pyk2 and FAK signaling, it would be informative to know whether 
certain integrin subtypes—in addition to overall levels of adhesion—are responsible for 
activating Pyk2 versus FAK and subsequent downstream functions.  FAK has been 
shown to couple to integrin αvβ5 in response to VEGF to promote angiogenesis (Eliceiri 
et al., 2002).  Indirectly, we have observed increased gene expression in cells cultured on 
low versus high densities of several ECM proteins—fibronectin, vitronectin, and 
laminin—and did not observe a significant effect on gene expression with knockdown of 
various integrin subunits (not shown).  These data suggest that Pyk2-mediated gene 
expression may be responsive to overall levels of adhesion but not necessarily to specific 
integrin signaling, although more direct experiments—such as examining whether Pyk2 
couples to specific integrins in response to VEGF or looking at Pyk2 and FAK activity in 
response to function blocking or knockdown of specific integrins—would be useful.  
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Further downstream, we have identified a set of transcription factors that could be 
responsible for the differences in gene expression observed between more and less 
adherent cells.  Additional studies are needed to determine if specific transcription factors 
are master regulators of large sets of adhesion-responsive genes in endothelial cells and 
whether these factors are controlled by Pyk2 signaling. 
5.2.3 Role of multicellular interactions in ECM regulation of angiogenesis 
 While several studies have now investigated ECM regulation of both single 
endothelial cell behavior and complex multicellular sprouting, we still do not understand 
how endothelial cell interactions with other endothelial cells and supporting 
mesenchymal cells affect this regulation.  It is known that cell-cell contact affects cell-
ECM interactions (Adams et al., 1998, Zhu, 1996 #197, Levenberg, 1998 #198; 
Levenberg et al., 1998; Zhu and Watt, 1996) and vice versa (Wang et al., 2006).  In our 
studies, while we observed increased gene expression in single endothelial cells cultured 
in limited adhesive contexts, this response was inhibited in confluent endothelial cells of 
similar spread areas.  This result could potentially correlate with quiescent cells in a 
vascular monolayer, as opposed to actively sprouting endothelial cells that have lost 
many of their cell-cell contacts.  It would be interesting to look at gene expression 
patterns in quiescent and actively angiogenic vessels in situ to see any differences in 
confluent versus sprouting endothelial cells, as well as in confluent regions with VE-
cadherin contacts disrupted.  Work from our lab has also demonstrated a requirement for 
cell-cell contact for endothelial cells to proliferate in response to mechanical stretch (Liu 
et al., 2007).  These results, along with work demonstrating increased proliferation of 
endothelial monolayers at regions of higher stress (Nelson et al., 2005), provide one 
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potential explanation for increased proliferation of stalk cells in angiogenic sprouts 
(Gerhardt et al., 2003), with migrating tip cells pulling and propagating stress toward 
stalk cells at the base of the sprouts.   
 In addition to homotypic endothelial cell-cell interactions, it will be essential to 
understand the role of supporting mesenchymal cells—in particular pericytes and smooth 
muscle cells—in controlling angiogenic response to changes in ECM properties.  While it 
is traditionally thought that endothelial tip cells are the first to sprout and interact with a 
new matrix, could it be possible that pericytes first sprout and provide a path for 
endothelial cells to follow?  This possibility is substantiated by the empty basement 
membrane “sleeves” and accompanying pericytes left behind after vessels regressed in 
response to inhibition of VEGF receptor—which quickly promoted revascularization 
upon withdrawal of the drug (Mancuso et al., 2006).  If pericytes are indeed early tip cells 
and depositers of new matrix, it will be important to study how ECM properties regulate 
both pericyte and endothelial cell behavior, as well as how much endothelial cells are 
interacting with pericyte-deposited matrix as opposed to the initial matrix present.  Our 
lab has recently obtained mice in which both endothelial and pericyte/smooth muscle 
cells are labeled, which should greatly enable studies to probe these questions.   
 
5.3 Remaining engineering challenges and potential solutions 
5.3.1 Optimizing design and control of synthetic materials 
 Toward our goal of developing tunable synthetic materials for tissue 
vascularization, significant progress has been made with the development of PEG 
hydrogels that are mechanically tunable and can be functionalized in a modular fashion 
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with adhesive, degradable, and pro-angiogenic factor-presenting properties.  Several 
challenges still remain, though.  While these materials allow for more independent 
control of parameters than native ECM matrices, there is still some coupling between 
parameters, for example differences in the ability of MMPs to access and degrade 
hydrogels with changes in weight percent to vary mechanical properties, or our 
observation that lower concentrations of adhesive peptide (with constant concentration of 
total mono-acrylated peptide) may render gels more degradable.  While it is unlikely that 
we can decouple parameters completely, we can nonetheless try to compensate for 
accompanying parameter shifts using our materials toolbox.  For instance, less 
degradable peptide sequences can be used in lower weight percent or lower adhesive 
peptide materials such that degradability is not affected by changes in mechanical 
stiffness or adhesive ligand density.  While this precise control is useful for mechanistic 
studies of angiogenesis, it may ultimately not be so necessary for applications in 
vascularizing implanted engineered tissues.  Indeed, we only need to be able to achieve 
the desired degree and timing of vascularization and to ensure any other encapsulated 
cells are well supported by the material. 
An additional challenge is the incorporation, retention, and appropriate release of 
growth factors from synthetic materials.  These materials do not possess growth factor 
binding sites as many native ECMs do, and thus retention and in vivo-like presentation of 
growth factors is difficult to achieve.  For angiogenesis in particular, growth factors need 
to be released to attract vessel ingrowth but also retained in the material for appropriate 
network formation.  Several advances have been made in this area, however, including 
the covalent binding of VEGF that can be subsequently released by proteolytic 
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degradation as cells migrate through the material (Zisch et al., 2003), as well as the 
covalent incorporation of heparin as a way to sequester endogenously present growth 
factors that closely recapitulates how native materials retain growth factors (Sakiyama-
Elbert and Hubbell, 2000).  Indeed, it will likely be beneficial to incorporate more 
biomimetic components to take advantage of both the control afforded by synthetic 
approaches and the established efficacy of natural principles.  A recent example employs 
factor XIII—which crosslinks fibrin gels—as a means to crosslink synthetic materials 
(Ehrbar et al., 2007).   
5.3.2 Engineering an angiogenic sprout 
 To test our hypothesis that adhesive and mechanical gradients along an 
angiogenic sprout are in part responsible for the different phenotypes observed, it would 
be useful to engineer a system that recapitulated elements of a sprouting vessel.  For 
example, one could start with a channel through an ECM material lined with endothelial 
cells, similar to the model developed by Tien and colleagues (Chrobak et al., 2006).  
Using a synthetic material that can be patterned with gradients or alternating lines of 
adhesive ligand or varying mechanical properties, we could test whether regions of 
higher adhesive ligand density or mechanical stiffness promoted proliferation, or whether 
regions of lower ECM density promoted an invasive phenotype and were locations of 
new sprouting off the existing channel.  The engineered vessel could also be 
mechanically stretched, similar to an approach by Mooney and colleagues (Matsumoto et 
al., 2007), to assess whether regions of higher strain—potentially similar to strains 
experienced by stalk cells—promote proliferation, or whether these strains dictate the 
location of neovessel sprouting. 
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5.4 Concluding Remarks 
 
Multiple properties of the ECM—from mechanical stiffness to presentation of 
adhesive ligands—are crucial regulators of angiogenesis.  While the effects of integrin-
mediated adhesion, cell spreading, and matrix stiffness are being explored, many basic 
questions remain:  how do these properties interact in regulating angiogenesis?  Is there 
an “optimal” angiogenic response or are there merely variations in the quality of 
angiogenesis, and can these responses be traced directly back to specific signaling 
pathways responsive to changes in cell-ECM interaction?  In order to answer such 
questions, knowledge and expertise in materials engineering and biology need to be 
tightly coupled.  To engineer materials that optimize vascular ingrowth to support 
implanted tissues, we need to take advantage of our basic knowledge of how ECM ligand 
presentation, stiffness, and degradation, as well as soluble factor cues and cell-cell 
interactions, regulate angiogenesis.  Similarly, we can utilize tools available to control 
material properties and cellular interactions precisely and systematically to further our 
understanding of the basic processes of angiogenesis.  This thesis has aimed to integrate 
biology and engineering by using microfabrication and synthetic materials tools to study 
ECM regulation of angiogenesis in a more controlled manner, as well as utilizing basic 
biological knowledge to design materials for therapeutic angiogenesis and tissue 
engineering.   
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